Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Open in Screener

RXST

RxSight Inc

Jan 17 • 04:00PM ET

30.39

Dollar change -0.79
Percentage change -2.53	%

Healthcare • Medical Devices • USA • NASD

Peers: STAA ALGN ICUI EW BSX MDT SYK TFX BAX XRAY

| Held by: VTI IWM VXF IWO VTWO SCHA VHT XHE DFAS DFAC

Index	RUT	P/E	-	EPS (ttm)	-0.82	Insider Own	5.05%	Shs Outstand	40.25M	Perf Week	-9.09%
Market Cap	1.22B	Forward P/E	-	EPS next Y	-0.45	Insider Trans	-3.62%	Shs Float	38.27M	Perf Month	-21.04%
Income	-30.69M	PEG	-	EPS next Q	-0.17	Inst Own	84.49%	Short Float	6.72%	Perf Quarter	-40.01%
Sales	128.29M	P/S	9.55	EPS this Y	48.73%	Inst Trans	2.46%	Short Ratio	3.69	Perf Half Y	-33.99%
Book/sh	6.89	P/B	4.41	EPS next Y	37.70%	ROA	-12.47%	Short Interest	2.57M	Perf Year	-33.28%
Cash/sh	5.88	P/C	5.17	EPS next 5Y	-	ROE	-13.99%	52W Range	26.29 - 66.54	Perf YTD	-11.61%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-10.66%	52W High	-54.33%	Beta	1.19
Dividend TTM	-	Quick Ratio	11.71	Sales past 5Y	201.89%	Gross Margin	68.44%	52W Low	15.60%	ATR (14)	2.06
Dividend Ex-Date	-	Current Ratio	12.67	EPS Y/Y TTM	52.45%	Oper. Margin	-30.46%	RSI (14)	30.11	Volatility	9.59% 5.50%
Employees	374	Debt/Eq	0.04	Sales Y/Y TTM	67.51%	Profit Margin	-23.92%	Recom	1.40	Target Price	54.50
Option/Short	Yes / Yes	LT Debt/Eq	0.04	EPS Q/Q	54.24%	Payout	-	Rel Volume	0.90	Prev Close	31.18
Sales Surprise	0.71%	EPS Surprise	35.04%	Sales Q/Q	59.08%	Earnings	Nov 07 AMC	Avg Volume	697.09K	Price	30.39
SMA20	-10.43%	SMA50	-24.17%	SMA200	-39.39%	Trades		Volume	627,464	Change	-2.53%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-20-24	Downgrade	Stifel	Buy → Hold	$65 → $40
Dec-11-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$56 → $42
Dec-06-24	Initiated	UBS	Buy	$52
Oct-29-24	Initiated	Jefferies	Buy	$72
Aug-20-24	Reiterated	Needham	Buy	$54 → $66
Aug-06-24	Reiterated	Needham	Buy	$75 → $54
May-07-24	Reiterated	BTIG Research	Buy	$61 → $72
Dec-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$31 → $42
Dec-12-23	Initiated	Stifel	Buy	$40
Dec-04-23	Initiated	Morgan Stanley	Overweight	$36
Apr-13-23	Initiated	Oppenheimer	Outperform	$23
Dec-12-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$20 → $14
Apr-08-22	Initiated	Needham	Buy	$18

Show Previous Ratings

Today 07:55AM	RxSight price target lowered to $43 from $66 at Needham (TipRanks)
Jan-12-25 09:30AM	RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance (GlobeNewswire)
Jan-02-25 04:05PM	RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-20-24 09:43AM	Do You Believe in the Long-Term Growth Potential of RxSight (RXST)? (Insider Monkey) -11.86%
Nov-20-24 12:00PM	RxSight (RXST) Upgraded to Buy: Here's What You Should Know (Zacks)
12:02PM	Loading…
Nov-08-24 12:02PM	RxSight Inc (RXST) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Market ... (GuruFocus.com) -5.59%
Nov-07-24 07:00PM	RxSight, Inc. (RXST) Reports Break-Even Earnings for Q3 (Zacks) -7.09%
04:05PM	RxSight, Inc. Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-06-24 07:16AM	What To Expect From RxSight Inc (RXST) Q3 2024 Earnings (GuruFocus.com) +5.80%
Oct-24-24 04:05PM	RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024 (GlobeNewswire)
Oct-15-24 06:10PM	RxSight, Inc. (RXST): A Visionary Small-Cap Stock Pick by Hedge Funds (Insider Monkey)
Oct-13-24 05:33PM	RxSight, Inc. (RXST): Top Investors Are Investing In This Small-Cap Stock Now (Insider Monkey)
Aug-22-24 04:05PM	RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences (GlobeNewswire)
Aug-19-24 03:43PM	RxSight Stock Sees Relative Strength Rating Rise To 91 (Investor's Business Daily)
Aug-12-24 09:55AM	Does RxSight (RXST) Have the Potential to Rally 27.64% as Wall Street Analysts Expect? (Zacks)
09:55AM	Loading…
Aug-06-24 09:55AM	Q2 2024 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) +17.34%
Aug-05-24 06:10PM	RxSight, Inc. (RXST) Reports Break-Even Earnings for Q2 (Zacks)
04:05PM	RxSight, Inc. Reports Second Quarter 2024 Financial Results (GlobeNewswire)
11:20AM	The 3 Best Med Tech Stocks to Buy Now (InvestorPlace)
Jul-29-24 09:35AM	Down -26.04% in 4 Weeks, Here's Why RxSight (RXST) Looks Ripe for a Turnaround (Zacks)
Jul-22-24 04:05PM	RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024 (GlobeNewswire)
Jul-12-24 09:35AM	RxSight (RXST) Loses -16.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Jul-10-24 10:59AM	Dow Flat As Nasdaq, S&P 500 Rise Again; Gold Stocks Rally, But These Growth Players Get Hit (Live Coverage) (Investor's Business Daily) -10.32%
Jun-18-24 01:50AM	Insider Sale: Director Julie Andrews Sells 15,625 Shares of RxSight Inc (RXST) (GuruFocus.com)
Jun-13-24 11:22AM	Eye Care Innovator In Buy Zone; 176% Growth Expected For IBD 50 Stock (Investor's Business Daily)
Jun-07-24 02:40PM	These 5 Companies Lost Money. Here's Why They're Still On The IBD 50. (Investor's Business Daily)
Jun-05-24 04:05PM	RxSight, Inc. To Participate in the Truist Securities Medtech Conference (GlobeNewswire)
May-30-24 04:00AM	Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board (GlobeNewswire)
May-28-24 12:00PM	What Makes RxSight, Inc. (RXST) a Strong Momentum Stock: Buy Now? (Zacks)
May-24-24 11:40AM	Why Top-Rated Medtech RxSight Has 20/20 Vision And Is Seeing 50% Growth (Investor's Business Daily)
04:58PM	Loading…
May-13-24 04:58PM	RxSight Raises $115 Million From Public Offering of Shares (MT Newswires)
04:05PM	RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
May-08-24 09:15PM	RxSight, Inc. Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
04:05PM	RxSight, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
May-07-24 12:17PM	Wells Fargo Adjusts RxSight Price Target to $68 From $61, Maintains Overweight Rating (MT Newswires)
08:50AM	RxSight, Inc. (NASDAQ:RXST) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:49AM	Needham Adjusts Price Target on RxSight to $75 From $64, Maintains Buy Rating (MT Newswires)
08:48AM	Oppenheimer Adjusts RxSight Price Target to $72 From $61, Maintains Outperform Rating (MT Newswires)
08:28AM	BTIG Adjusts Price Target on RxSight to $72 From $61, Maintains Buy Rating (MT Newswires)
06:42AM	Q1 2024 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
04:26AM	RxSight Q1 Adjusted Loss Narrows, Revenue Rises (MT Newswires)
03:10AM	RxSight Inc (RXST) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-06-24 05:37PM	RxSight Inc (RXST) Surpasses Analyst Revenue Forecasts in Q1 2024 (GuruFocus.com)
05:06PM	Rxsight Insider Sold Shares Worth $2,405,872, According to a Recent SEC Filing (MT Newswires)
04:05PM	RxSight, Inc. Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-02-24 05:03PM	Rxsight Insider Sold Shares Worth $526,913, According to a Recent SEC Filing (MT Newswires) +5.17%
May-01-24 04:05PM	RxSight, Inc. to Present at the Bank of America Healthcare Conference (GlobeNewswire) +8.77%
Apr-22-24 04:05PM	RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024 (GlobeNewswire)
Apr-04-24 04:05PM	RxSight Announces Commercial Launch of its Newest Light Adjustable Lens , the LAL+ , and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting (GlobeNewswire) +6.08%
Mar-27-24 04:05PM	RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Feb-29-24 07:05PM	RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference (GlobeNewswire)
11:09AM	RxSight, Inc. (NASDAQ:RXST) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:36AM	Q4 2023 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-28-24 04:38PM	RxSight Inc (RXST) Reports Significant Revenue Growth in Q4 and Full Year 2023 (GuruFocus.com)
04:05PM	RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-14-24 04:05PM	RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 (GlobeNewswire)
Jan-19-24 05:01PM	Director Shweta Maniar Sells 6,399 Shares of RxSight Inc (GuruFocus.com)
Jan-12-24 03:16PM	3 Stocks to Buy BEFORE They Become Household Names (InvestorPlace)
Jan-09-24 06:19PM	RxSight, Inc. (RXST) Just Overtook the 20-Day Moving Average (Zacks)
Jan-07-24 10:00AM	RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance (GlobeNewswire)
Dec-27-23 04:05PM	RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-15-23 09:30AM	RxSight, Inc. (RXST) Recently Broke Out Above the 50-Day Moving Average (Zacks)
Nov-12-23 10:26AM	RxSight, Inc. (NASDAQ:RXST) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-10-23 07:42AM	Q3 2023 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) +6.22%
Nov-09-23 04:05PM	RxSight, Inc. Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-02-23 09:00AM	RxSight, Inc. Educational and Product Announcements for AAO 2023 (GlobeNewswire)
Oct-26-23 04:05PM	RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023 (GlobeNewswire) -5.43%
Sep-07-23 09:35AM	RxSight, Inc. (RXST) Crossed Above the 20-Day Moving Average: What That Means for Investors (Zacks)
Aug-23-23 04:05PM	RxSight, Inc. to Present at the Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-22-23 05:20PM	Has Alcon (ALC) Outpaced Other Medical Stocks This Year? (Zacks)
Aug-18-23 09:23AM	The Zacks Analyst Blog Highlights Abcam, Integer Holdings and RxSight (Zacks)
Aug-17-23 08:37AM	3 Medical Device Stocks With Potential to Fight Deflation Risk (Zacks)
Aug-08-23 08:44AM	RxSight, Inc. (NASDAQ:RXST) Q2 2023 Earnings Call Transcript (Insider Monkey)
06:21AM	Q2 2023 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 06:15PM	RxSight, Inc. (RXST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	RxSight, Inc. Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-25-23 04:05PM	RxSight, Inc. to Report Second Quarter Financial Results on August 7, 2023 (GlobeNewswire)
Jun-30-23 08:31AM	Strength Seen in RxSight, Inc. (RXST): Can Its 9.6% Jump Turn into More Strength? (Zacks)
Jun-27-23 08:38AM	Alphatec (ATEC) Surges 8.8%: Is This an Indication of Further Gains? (Zacks)
Jun-18-23 10:53AM	Investors in RxSight (NASDAQ:RXST) have seen respectable returns of 79% over the past year (Simply Wall St.)
May-10-23 07:52AM	Q1 2023 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) +9.87%
May-09-23 06:15PM	RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	RxSight, Inc. Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-03-23 10:00AM	Steris (STE) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
May-02-23 10:02AM	Will RxSight, Inc. (RXST) Report Negative Earnings Next Week? What You Should Know (Zacks)
Apr-26-23 06:33PM	2 Strong Buy Stocks Oppenheimer Predicts Will Surge at Least 30% (TipRanks)
04:05PM	RxSight, Inc. to Present at the Bank of America Healthcare Conference (GlobeNewswire)
Apr-25-23 04:05PM	RxSight, Inc. to Report First Quarter Financial Results on May 9, 2023 (GlobeNewswire)
Apr-24-23 04:05PM	Multiple Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting (GlobeNewswire)
Apr-18-23 11:26AM	RxSight, Inc. (NASDAQ:RXST) Not Lagging Industry On Growth Or Pricing (Simply Wall St.)
Apr-11-23 12:00PM	Here's Why RxSight, Inc. (RXST) is a Great Momentum Stock to Buy (Zacks)
Apr-05-23 04:05PM	RxSight, Inc. to Present at the Needham Healthcare Conference (GlobeNewswire)
Mar-13-23 09:55AM	How Much Upside is Left in RxSight, Inc. (RXST)? Wall Street Analysts Think 25.69% (Zacks)
Mar-08-23 07:21AM	RxSight, Inc. (NASDAQ:RXST) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-07-23 08:23AM	Q4 2022 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
05:16AM	RxSight, Inc.'s (NASDAQ:RXST) biggest owners are individual investors who got richer after stock soared 14% last week (Simply Wall St.)
Mar-06-23 04:05PM	RxSight, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire) +12.96%
Feb-28-23 04:05PM	RxSight, Inc. to Present at the Oppenheimer Healthcare Conference (GlobeNewswire)
Feb-21-23 04:05PM	RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 6, 2023 (GlobeNewswire)
Feb-14-23 04:05PM	RxSight, Inc. Announces Full Exercise of Underwriters Option to Purchase Additional Shares and Closing of its Public Offering of Common Stock (GlobeNewswire)

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Corley Jesse Anderson	Director	Jan 16 '25	Buy	31.13	1,767	55,004	3,210	Jan 17 07:08 PM
Corley Jesse Anderson	Director	Jan 15 '25	Buy	31.18	1,443	45,000	1,443	Jan 17 07:08 PM
Goldshleger Ilya	See remarks	Nov 29 '24	Option Exercise	15.08	3,105	46,823	45,351	Dec 03 06:38 PM
Goldshleger Ilya	See remarks	Nov 29 '24	Sale	46.08	3,105	143,078	42,246	Dec 03 06:38 PM
ILYA GOLDSHLEGER	Officer	Nov 29 '24	Proposed Sale	46.08	3,105	143,078		Nov 29 01:29 PM
Maniar Shweta	Director	Nov 26 '24	Sale	45.88	3,782	173,518	10,902	Nov 26 07:26 PM
Goldshleger Ilya	See remarks	Nov 22 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 26 07:25 PM
Goldshleger Ilya	See remarks	Nov 26 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 26 07:25 PM
Goldshleger Ilya	See remarks	Nov 26 '24	Sale	45.88	3,100	142,228	42,246	Nov 26 07:25 PM
Goldshleger Ilya	See remarks	Nov 22 '24	Sale	45.00	3,100	139,500	42,246	Nov 26 07:25 PM
ILYA GOLDSHLEGER	Officer	Nov 26 '24	Proposed Sale	45.88	3,100	142,228		Nov 26 04:13 PM
Maniar Shweta	Director	Nov 26 '24	Proposed Sale	45.88	3,782	173,518		Nov 26 02:45 PM
ILYA GOLDSHLEGER	Officer	Nov 22 '24	Proposed Sale	45.00	3,100	139,500		Nov 22 04:15 PM
Goldshleger Ilya	See remarks	Nov 15 '24	Option Exercise	15.08	4,875	73,515	47,121	Nov 18 09:50 PM
Goldshleger Ilya	See remarks	Nov 18 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 18 09:50 PM
Goldshleger Ilya	See remarks	Nov 15 '24	Sale	46.00	4,875	224,250	42,246	Nov 18 09:50 PM
Goldshleger Ilya	See remarks	Nov 18 '24	Sale	45.00	3,100	139,502	42,246	Nov 18 09:50 PM
ILYA GOLDSHLEGER	Officer	Nov 18 '24	Proposed Sale	45.00	3,100	139,502		Nov 18 04:29 PM
ILYA GOLDSHLEGER	Officer	Nov 15 '24	Proposed Sale	46.00	4,875	224,250		Nov 15 04:18 PM
Goldshleger Ilya	See remarks	Nov 12 '24	Option Exercise	15.08	1,330	20,056	43,576	Nov 14 07:42 PM
Goldshleger Ilya	See remarks	Nov 12 '24	Sale	46.13	1,330	61,356	42,246	Nov 14 07:42 PM
Corley Jesse Anderson	Director	Nov 12 '24	Buy	45.37	11,111	504,079	468,571	Nov 14 07:14 PM
Corley Jesse Anderson	Director	Nov 13 '24	Buy	44.84	5,795	259,841	38,438	Nov 14 07:14 PM
Corley Jesse Anderson	Director	Nov 13 '24	Buy	45.00	5,570	250,650	474,141	Nov 14 07:14 PM
ILYA GOLDSHLEGER	Officer	Nov 12 '24	Proposed Sale	46.13	1,330	61,356		Nov 12 05:38 PM
Goldshleger Ilya	See remarks	Nov 07 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 08 04:00 PM
Goldshleger Ilya	See remarks	Nov 07 '24	Sale	55.00	3,100	170,495	42,246	Nov 08 04:00 PM
ILYA GOLDSHLEGER	Officer	Nov 07 '24	Proposed Sale	55.00	3,100	170,494		Nov 07 04:14 PM
Goldshleger Ilya	See remarks	Nov 04 '24	Option Exercise	15.08	3,100	46,748	45,346	Nov 05 04:05 PM
Goldshleger Ilya	See remarks	Nov 04 '24	Sale	51.05	3,100	158,247	42,246	Nov 05 04:05 PM
ILYA GOLDSHLEGER	Officer	Nov 04 '24	Proposed Sale	51.05	3,100	158,247		Nov 04 04:17 PM
Goldshleger Ilya	See remarks	Oct 30 '24	Option Exercise	15.08	3,105	46,823	45,351	Oct 31 05:22 PM
Goldshleger Ilya	See remarks	Oct 30 '24	Sale	51.91	3,105	161,171	42,246	Oct 31 05:22 PM
LYA GOLDSHLEGER	Officer	Oct 30 '24	Proposed Sale	51.91	3,105	161,171		Oct 30 04:28 PM
Goldshleger Ilya	See remarks	Oct 25 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 28 08:55 PM
Goldshleger Ilya	See remarks	Oct 28 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 28 08:55 PM
Goldshleger Ilya	See remarks	Oct 28 '24	Sale	50.64	3,100	156,993	42,246	Oct 28 08:55 PM
Goldshleger Ilya	See remarks	Oct 25 '24	Sale	49.79	3,100	154,360	42,246	Oct 28 08:55 PM
ILYA GOLDSHLEGER	Officer	Oct 28 '24	Proposed Sale	50.64	3,100	156,993		Oct 28 04:15 PM
ILYA GOLDSHLEGER	Officer	Oct 25 '24	Proposed Sale	49.79	3,100	154,360		Oct 25 04:15 PM
Goldshleger Ilya	See remarks	Oct 22 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 22 08:17 PM
Goldshleger Ilya	See remarks	Oct 22 '24	Sale	49.68	3,100	154,001	42,246	Oct 22 08:17 PM
ILYA GOLDSHLEGER	Officer	Oct 22 '24	Proposed Sale	49.68	3,100	154,001		Oct 22 04:16 PM
Goldshleger Ilya	See remarks	Oct 18 '24	Option Exercise	15.08	3,105	46,823	45,351	Oct 18 05:23 PM
Goldshleger Ilya	See remarks	Oct 16 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 18 05:23 PM
Goldshleger Ilya	See remarks	Oct 18 '24	Sale	50.09	3,105	155,533	42,246	Oct 18 05:23 PM
Goldshleger Ilya	See remarks	Oct 16 '24	Sale	49.78	3,100	154,318	42,246	Oct 18 05:23 PM
ILYA GOLDSHLEGER	Officer	Oct 18 '24	Proposed Sale	50.09	3,105	155,533		Oct 18 04:23 PM
ILYA GOLDSHLEGER	Officer	Oct 16 '24	Proposed Sale	49.78	3,100	154,317		Oct 16 04:16 PM
Goldshleger Ilya	See remarks	Oct 10 '24	Option Exercise	15.08	3,105	46,823	45,351	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 11 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 14 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 11 '24	Sale	50.19	3,100	155,594	42,246	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 14 '24	Sale	50.09	3,100	155,268	42,246	Oct 15 04:23 PM
Goldshleger Ilya	See remarks	Oct 10 '24	Sale	48.82	3,105	151,596	42,246	Oct 15 04:23 PM
ILYA GOLDSHLEGER	Officer	Oct 14 '24	Proposed Sale	50.09	3,100	155,268		Oct 15 08:23 AM
ILYA GOLDSHLEGER	Officer	Oct 11 '24	Proposed Sale	50.19	3,100	155,593		Oct 11 04:17 PM
ILYA GOLDSHLEGER	Officer	Oct 10 '24	Proposed Sale	48.82	3,105	151,595		Oct 10 04:11 PM
Goldshleger Ilya	See remarks	Oct 04 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 08 06:00 PM
Goldshleger Ilya	See remarks	Oct 08 '24	Option Exercise	15.08	3,100	46,748	45,346	Oct 08 06:00 PM
Goldshleger Ilya	See remarks	Oct 08 '24	Sale	48.26	3,100	149,612	42,246	Oct 08 06:00 PM
Goldshleger Ilya	See remarks	Oct 04 '24	Sale	48.01	3,100	148,824	42,246	Oct 08 06:00 PM
ILYA GOLDSHLEGER	Officer	Oct 08 '24	Proposed Sale	48.26	3,100	149,612		Oct 08 04:19 PM
ILYA GOLDSHLEGER	Officer	Oct 04 '24	Proposed Sale	48.01	3,100	148,824		Oct 04 04:23 PM
Thunen Shelley B	See remarks	Oct 01 '24	Option Exercise	16.00	15,000	240,000	45,443	Oct 02 04:11 PM
Thunen Shelley B	See remarks	Oct 01 '24	Sale	48.45	15,000	726,730	30,443	Oct 02 04:11 PM
SHELLEY B THUNEN	Officer	Oct 01 '24	Proposed Sale	48.45	15,000	726,729		Oct 01 04:24 PM
Goldshleger Ilya	See remarks	Sep 26 '24	Option Exercise	15.08	3,105	46,823	45,351	Sep 30 08:05 PM
Goldshleger Ilya	See remarks	Sep 30 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 30 08:05 PM
Goldshleger Ilya	See remarks	Sep 26 '24	Sale	49.29	3,105	153,054	42,246	Sep 30 08:05 PM
Goldshleger Ilya	See remarks	Sep 30 '24	Sale	49.02	3,100	151,947	42,246	Sep 30 08:05 PM
ILYA GOLDSHLEGER	Officer	Sep 30 '24	Proposed Sale	49.02	3,100	151,946		Sep 30 04:14 PM
ILYA GOLDSHLEGER	Officer	Sep 26 '24	Proposed Sale	49.29	3,105	153,054		Sep 26 04:09 PM
Goldshleger Ilya	See remarks	Sep 20 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 23 06:48 PM
Goldshleger Ilya	See remarks	Sep 23 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 23 06:48 PM
Goldshleger Ilya	See remarks	Sep 20 '24	Sale	53.19	3,100	164,901	42,246	Sep 23 06:48 PM
Goldshleger Ilya	See remarks	Sep 23 '24	Sale	52.67	3,100	163,263	42,246	Sep 23 06:48 PM
ILYA GOLDSHLEGER	Officer	Sep 23 '24	Proposed Sale	52.67	3,100	163,263		Sep 23 04:08 PM
ILYA GOLDSHLEGER	Officer	Sep 20 '24	Proposed Sale	53.19	3,100	164,901		Sep 20 04:08 PM
Goldshleger Ilya	See remarks	Sep 17 '24	Option Exercise	15.08	3,100	46,748	45,346	Sep 18 04:41 PM
Goldshleger Ilya	See remarks	Sep 17 '24	Sale	56.11	3,100	173,944	42,246	Sep 18 04:41 PM
ILYA GOLDSHLEGER	Officer	Sep 17 '24	Proposed Sale	56.11	3,100	173,943		Sep 17 04:15 PM
Kurtz Ronald M MD	President & CEO	Aug 09 '24	Option Exercise	12.60	9,950	125,355	63,450	Aug 09 05:57 PM
Goldshleger Ilya	See remarks	Aug 05 '24	Sale	39.25	9,000	353,291	42,246	Aug 06 04:19 PM
ILYA GOLDSHLEGER	Officer	Aug 05 '24	Proposed Sale	39.25	9,000	353,290		Aug 05 04:08 PM
Thunen Shelley B	See remarks	Jul 15 '24	Option Exercise	4.34	16,505	71,632	30,443	Jul 16 08:15 PM
Kurtz Ronald M MD	President & CEO	Jul 11 '24	Option Exercise	15.08	13,500	203,604	53,500	Jul 12 07:12 PM
Thunen Shelley B	Chief Financial Officer	Jul 01 '24	Option Exercise	15.60	10,000	155,983	23,938	Jul 02 04:25 PM
Thunen Shelley B	Chief Financial Officer	Jul 01 '24	Sale	58.61	10,000	586,055	13,938	Jul 02 04:25 PM
Thunen Shelley B	Chief Financial Officer	Jul 01 '24	Sale	58.77	8,402	493,760	0	Jul 02 04:25 PM
Andrews Julie	Director	Jun 14 '24	Sale	58.00	15,625	906,288	30,287	Jun 17 06:45 PM
Tammenoms Bakker Juliet	Director	May 17 '24	Buy	61.09	5,000	305,456	34,840	May 21 04:11 PM
Goldshleger Ilya	Chief Operating Officer	May 17 '24	Option Exercise	4.04	24,771	100,066	51,246	May 20 04:56 PM
Kurtz Ronald M MD	President & CEO	May 03 '24	Sale	60.15	40,000	2,405,872	764,610	May 06 05:02 PM
Thunen Shelley B	Chief Financial Officer	May 01 '24	Option Exercise	15.60	10,247	159,836	23,938	May 02 04:58 PM
Thunen Shelley B	Chief Financial Officer	May 01 '24	Sale	52.69	10,000	526,913	13,938	May 02 04:58 PM
Thunen Shelley B	Chief Financial Officer	Apr 01 '24	Sale	49.90	20,000	997,946	8,402	Apr 02 04:18 PM
Thunen Shelley B	Chief Financial Officer	Mar 01 '24	Option Exercise	15.60	10,000	155,983	23,691	Mar 05 04:05 PM
Thunen Shelley B	Chief Financial Officer	Mar 01 '24	Sale	56.37	10,000	563,726	13,691	Mar 05 04:05 PM
Goldshleger Ilya	Chief Operating Officer	Feb 15 '24	Option Exercise	23.04	10,000	230,400	36,475	Feb 16 05:00 PM

Dollar change +0.44
Percentage change 1.99	%

STAA Staar Surgical Co daily Stock Chart

Peers: JNJ ALGN ISRG MDT ABT NVS BSX EW EYE SYK

| Held by: IJR VTI VB IWM VXF VBK SPSM IWO IJT VTWO

Index	RUT	P/E	50.88	EPS (ttm)	0.44	Insider Own	0.63%	Shs Outstand	49.27M	Perf Week	-3.09%
Market Cap	1.10B	Forward P/E	29.68	EPS next Y	0.75	Insider Trans	55.57%	Shs Float	48.97M	Perf Month	-6.85%
Income	21.78M	PEG	1.70	EPS next Q	-0.04	Inst Own	97.61%	Short Float	7.22%	Perf Quarter	-30.47%
Sales	341.22M	P/S	3.22	EPS this Y	-31.81%	Inst Trans	2.22%	Short Ratio	5.62	Perf Half Y	-48.33%
Book/sh	8.69	P/B	2.57	EPS next Y	9.05%	ROA	4.32%	Short Interest	3.54M	Perf Year	-24.39%
Cash/sh	4.79	P/C	4.65	EPS next 5Y	30.00%	ROE	5.40%	52W Range	21.13 - 52.68	Perf YTD	-8.23%
Dividend Est.	-	P/FCF	41.76	EPS past 5Y	31.51%	ROI	4.70%	52W High	-57.69%	Beta	0.63
Dividend TTM	-	Quick Ratio	5.38	Sales past 5Y	21.65%	Gross Margin	78.73%	52W Low	5.49%	ATR (14)	1.24
Dividend Ex-Date	-	Current Ratio	5.99	EPS Y/Y TTM	10.40%	Oper. Margin	7.53%	RSI (14)	37.12	Volatility	4.60% 5.14%
Employees	1115	Debt/Eq	0.09	Sales Y/Y TTM	10.01%	Profit Margin	6.38%	Recom	2.08	Target Price	39.81
Option/Short	Yes / Yes	LT Debt/Eq	0.08	EPS Q/Q	105.64%	Payout	0.00%	Rel Volume	0.78	Prev Close	21.85
Sales Surprise	1.94%	EPS Surprise	44.52%	Sales Q/Q	10.31%	Earnings	Oct 30 AMC	Avg Volume	628.49K	Price	22.29
SMA20	-5.62%	SMA50	-13.63%	SMA200	-37.64%	Trades		Volume	490,913	Change	1.99%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-15-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$50 → $37
Jun-11-24	Upgrade	BTIG Research	Neutral → Buy	$46
Mar-11-24	Upgrade	Stifel	Hold → Buy	$30 → $50
Dec-05-23	Downgrade	Needham	Buy → Hold
Dec-04-23	Initiated	Morgan Stanley	Equal-Weight	$35
Sep-15-23	Downgrade	The Benchmark Company	Buy → Hold
Aug-03-23	Downgrade	Canaccord Genuity	Buy → Hold	$77 → $48
Jun-07-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-17-23	Initiated	Piper Sandler	Neutral	$65
Feb-06-23	Downgrade	BTIG Research	Buy → Neutral
Dec-28-22	Reiterated	BTIG Research	Buy	$80 → $67
Dec-08-22	Initiated	Stifel	Hold	$60
Nov-07-22	Upgrade	Sidoti	Neutral → Buy
Oct-14-22	Resumed	Stephens	Overweight	$91
Oct-13-22	Initiated	Mizuho	Buy	$85
Apr-08-22	Initiated	Needham	Buy	$87
Mar-28-22	Upgrade	The Benchmark Company	Hold → Buy	$97
Mar-18-22	Upgrade	BTIG Research	Neutral → Buy	$98
Jul-09-21	Initiated	Oppenheimer	Perform	$150
Jan-19-21	Downgrade	The Benchmark Company	Buy → Hold

Show Previous Ratings

Jan-13-25 07:00AM	STAAR Surgical to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast on February 19, 2025 (Business Wire)
Jan-04-25 07:50AM	Staar Surgical price target lowered to $39 from $49 at BTIG (TipRanks)
Nov-25-24 07:00AM	STAAR Surgical to Participate in BTIG Ophthalmology Day (Business Wire) +7.01%
Nov-13-24 10:05AM	Implied Volatility Surging for STAAR Surgical (STAA) Stock Options (Zacks)
07:00AM	STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024) (Business Wire)
09:15AM	Loading…
Nov-04-24 09:15AM	A Dive into Staar Surgical (STAA) International Revenue Trends and Forecasts (Zacks)
05:15AM	STAAR Surgical and Lucy Bronze, MBE, See Eye to Eye on Vision Correction (PR Newswire)
Nov-02-24 09:00AM	Staar Surgical Co (STAA) Q3 2024 Earnings Call Highlights: Strong Sales Growth Amidst Challenges (GuruFocus.com)
Oct-30-24 10:21PM	CORRECTING and REPLACING STAAR Surgical Reports Third Quarter 2024 Results (Business Wire)
05:35PM	Staar Surgical (STAA) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
04:33PM	Staar Surgical: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	STAAR Surgical Reports Third Quarter 2024 Results (Business Wire)
Oct-29-24 09:11AM	What To Expect From Staar Surgical Co (STAA) Q3 2024 Earnings (GuruFocus.com)
Oct-23-24 07:00AM	STAAR Surgical to Report Third Quarter Results on October 30, 2024 (Business Wire)
Oct-07-24 09:55AM	Here's Why Staar Surgical (STAA) Could be Great Choice for a Bottom Fisher (Zacks)
09:55AM	Loading…
Sep-27-24 09:55AM	Wall Street Analysts Predict a 43.93% Upside in Staar Surgical (STAA): Here's What You Should Know (Zacks) +9.92%
Sep-23-24 07:00AM	STAAR Surgical Experience Center Expands to Meet Growing Surgeon Demand (Business Wire)
Sep-17-24 08:00AM	Sidoti Events, LLC's Virtual September Small-Cap Conference (ACCESSWIRE)
Sep-16-24 12:00PM	Staar Surgical (STAA) Moves to Buy: Rationale Behind the Upgrade (Zacks)
Sep-06-24 01:01PM	Baillie Gifford Reduces Stake in Staar Surgical Co (GuruFocus.com)
Aug-13-24 10:48AM	Implied Volatility Surging for STAAR Surgical (STAA) Stock Options (Zacks)
Aug-12-24 09:15AM	Why Staar Surgical (STAA) International Revenue Trends Deserve Your Attention (Zacks)
Aug-07-24 11:53PM	STAA Stock Earnings: Staar Surgical Misses EPS, Beats Revenue for Q2 2024 (InvestorPlace) +11.03%
08:00PM	Staar Surgical (STAA) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:20PM	Staar Surgical (STAA) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
04:22PM	Staar Surgical: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	STAAR Surgical Reports Second Quarter 2024 Results (Business Wire)
Jul-31-24 07:00AM	STAAR Surgical to Report Second Quarter Results on August 7, 2024 (Business Wire)
Jul-30-24 07:00AM	STAAR Surgical to Participate in Canaccord Genuity 44th Annual Growth Conference (Business Wire)
Jun-27-24 01:25PM	Staar Surgical Stock Earns RS Rating Upgrade (Investor's Business Daily)
04:01AM	Loading…
04:01AM	Staar Surgical (STAA) Soars 7.5%: Is Further Upside Left in the Stock? (Zacks)
Jun-05-24 07:00AM	STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference (Business Wire)
May-13-24 11:06AM	Don't Overlook Staar Surgical (STAA) International Revenue Trends While Assessing the Stock (Zacks)
May-08-24 11:06AM	STAAR Surgical Company (NASDAQ:STAA) Q1 2024 Earnings Call Transcript (Insider Monkey) -12.07%
10:17AM	Mizuho Adjusts STAAR Surgical's Price Target to $55 From $53, Keeps Buy Rating (MT Newswires)
07:59AM	Morgan Stanley Raises Price Target on STAAR Surgical to $50 From $35, Keeps Equalweight Rating (MT Newswires)
03:43AM	Staar Surgical Co (STAA) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amid ... (GuruFocus.com)
May-07-24 11:54PM	STAA Stock Earnings: Staar Surgical Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
07:30PM	Staar Surgical (STAA) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
05:58PM	Staar Surgical Co Reports Q1 2024 Results: Misses Earnings Projections Despite Revenue Growth (GuruFocus.com)
05:26PM	Staar Surgical: Q1 Earnings Snapshot (Associated Press Finance)
04:03PM	STAAR Surgical Reports First Quarter 2024 Results (Business Wire)
04:01PM	STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision (Business Wire)
May-06-24 09:16AM	Wall Street's Insights Into Key Metrics Ahead of Staar Surgical (STAA) Q1 Earnings (Zacks)
May-01-24 07:00AM	STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel (Business Wire)
Apr-29-24 07:00AM	STAAR Surgical to Report First Quarter Results on May 7, 2024 (Business Wire)
Apr-25-24 03:43PM	Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating (Investor's Business Daily)
Apr-05-24 09:15AM	Strength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength? (Zacks) +6.97%
Apr-04-24 04:26PM	Staar Surgical, A Lasik Rival, Just Crushed Quarterly Views; But Is Its 2026 Target Too Aggressive? (Investor's Business Daily) +16.48%
03:54PM	Eye Lens Maker STAAR Surgical Expects Q1 Sales To Beat Consensus (Benzinga)
07:00AM	STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024 (Business Wire)
Apr-02-24 07:00AM	STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024 (Business Wire)
Mar-26-24 11:45AM	Nvidias Market Cap Myopia: 3 Stocks Proving Size Isnt Everything (InvestorPlace)
Mar-20-24 04:22AM	STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses (PR Newswire)
Mar-18-24 07:00AM	STAAR Surgical Celebrates Three Million Implantable Collamer Lenses (Business Wire)
Mar-12-24 10:30AM	Sidoti Events, LLC's Virtual March Small-Cap Conference (ACCESSWIRE)
07:00AM	STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors (Business Wire)
Mar-06-24 07:00AM	STAAR Surgical to Participate in Two Upcoming Investor Conferences (Business Wire) +6.67%
Feb-28-24 10:58AM	STAAR Surgical Company (NASDAQ:STAA) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 02:00PM	Staar Surgical (STAA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
Feb-26-24 05:30PM	Staar Surgical (STAA) Beats Q4 Earnings Estimates (Zacks)
04:39PM	Staar Surgical: Q4 Earnings Snapshot (Associated Press Finance)
04:34PM	Staar Surgical Co (STAA) Posts Solid Growth in Q4 and FY 2023, Affirms Positive Outlook for 2024 (GuruFocus.com)
04:01PM	STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results (Business Wire)
Feb-19-24 07:00AM	STAAR Surgical to Report Fourth Quarter Results on February 26, 2024 (Business Wire)
Jan-27-24 01:03PM	Baillie Gifford Adjusts Position in Staar Surgical Co (GuruFocus.com)
Jan-23-24 07:00AM	STAAR Surgical Announces Strategic Agreement in U.S. with SharpeVision (Business Wire)
Jan-12-24 06:49PM	Howard Hughes, Carrier, and More Stocks See Action From Activist Investors (Barrons.com) -5.14%
Jan-08-24 07:00AM	STAAR Surgical Announces Preliminary Results for Fourth Quarter and Fiscal 2023 (Business Wire) +11.52%
Dec-17-23 12:35PM	7 Stocks with Strong Insider Buying: December 2023 (InvestorPlace)
Dec-05-23 03:16AM	Lululemon Athletica gets one more downgrade ahead of Q3 report: 4 big analyst cuts (Investing.com)
Dec-04-23 04:05PM	Lilian Zhou Appointed to STAAR Surgical Board of Directors (Business Wire)
Nov-15-23 07:00AM	STAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023) (Business Wire)
Nov-02-23 05:50PM	STAAR Surgical Company (NASDAQ:STAA) Q3 2023 Earnings Call Transcript (Insider Monkey) -16.87%
09:23AM	Q3 2023 STAAR Surgical Co Earnings Call (Thomson Reuters StreetEvents)
Nov-01-23 06:30PM	Here's What Key Metrics Tell Us About Staar Surgical (STAA) Q3 Earnings (Zacks)
05:56PM	Staar Surgical Co (STAA) Reports 6% Y/Y Increase in Q3 2023 Net Sales (GuruFocus.com)
04:17PM	Staar Surgical: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	STAAR Surgical Reports Third Quarter 2023 Results (Business Wire)
Oct-31-23 04:40PM	Investor urges STAAR Surgical to spin off Asia unit - letter (Reuters)
Oct-18-23 04:05PM	STAAR Surgical to Report Third Quarter Results on November 1, 2023 (Business Wire)
Oct-17-23 07:00AM	STAAR Surgical Celebrates 30th Anniversary of Implantable Collamer Lens (ICL) (Business Wire)
Oct-13-23 06:30PM	Staar Surgical, Howard Hughes Holdings, and More Stocks See Action From Activist Investors (Barrons.com) +6.01%
Oct-10-23 10:51AM	Jimmy O. Yang Partners with STAAR Surgical to Shine a Light on Their Vision Correction Lens, EVO ICL (PR Newswire)
Sep-19-23 11:51AM	Is Staar Surgical Co (STAA) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
Sep-15-23 09:32AM	Shake Shack upgraded, DoorDash downgraded: Wall Street's top analyst calls (The Fly)
Sep-14-23 12:53PM	Is Staar Surgical Co (STAA) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
07:00AM	STAAR Surgical to Ring Nasdaq Stock Market Closing Bell Following Vision 2026 Investor Day on September 14, 2023 (Business Wire)
Sep-08-23 11:38AM	Staar Surgical Co (STAA): A Potential Value Trap? (GuruFocus.com)
Sep-07-23 05:00PM	STAAR Surgical to Host "Vision 2026" Investor Day on September 14, 2023 (Business Wire)
Aug-18-23 10:40AM	Dolby Labs jumps as S&P prepares to add it to its MidCap 400 index (Investing.com)
Aug-17-23 06:48PM	Dolby Laboratories Set to Join S&P MidCap 400; Staar Surgical to Join S&P SmallCap 600 (PR Newswire)
Aug-09-23 07:00AM	STAAR Surgical Teams Up With Tennessee Titans Quarterback Will Levis On Life Changing Vision Correction Procedure, EVO ICL (Business Wire)
Aug-07-23 07:00AM	STAAR Surgical to Participate in Upcoming Investor Conferences (Business Wire)
05:00AM	3 Strong Buy Growth Stocks You Should Be Loading Up On Now (InvestorPlace)
Aug-03-23 07:18PM	Why STAAR Surgical Stock Dropped Today (Motley Fool) -9.60%
Aug-02-23 05:25PM	Staar Surgical (STAA) Q2 Earnings Beat Estimates (Zacks)
04:21PM	Staar Surgical: Q2 Earnings Snapshot (AP Finance)
04:01PM	STAAR Surgical Reports Second Quarter 2023 Results (Business Wire)
Jul-19-23 07:00AM	STAAR Surgical to Report Second Quarter Results on August 2, 2023 (Business Wire)

STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 14 '25	Buy	21.46	21,155	454,086	10,869,786	Jan 16 07:20 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 16 '25	Buy	21.50	8,221	176,753	10,878,007	Jan 16 07:20 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Dec 16 '24	Buy	24.24	53,500	1,297,084	10,821,931	Dec 18 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Dec 18 '24	Buy	24.33	23,000	559,493	10,848,631	Dec 18 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Dec 17 '24	Buy	24.58	3,700	90,963	10,825,631	Dec 18 07:00 PM
Butcher Arthur C	Director	Aug 12 '24	Buy	37.99	1,315	49,957	4,208	Aug 19 05:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	May 09 '24	Buy	42.56	1	43	10,768,431	May 13 06:00 PM
WEISNER AIMEE S	Director	Mar 14 '24	Buy	38.11	1,750	66,692	10,864	Mar 14 05:23 PM
Williams Patrick F.	Chief Financial Officer	Mar 07 '24	Option Exercise	0.00	2,614	0	45,475	Mar 11 06:06 AM

Dollar change -1.64
Percentage change -6.25	%

Peers: AMZN TGT WMT COST BBY DG DLTR M KSS JWN

| Held by: VTI IWM VB VXF VBK IWO SCHA VTWO XRT DFAS

Index	RUT	P/E	-	EPS (ttm)	-0.27	Insider Own	26.43%	Shs Outstand	101.59M	Perf Week	-2.92%
Market Cap	2.96B	Forward P/E	76.07	EPS next Y	0.32	Insider Trans	-4.87%	Shs Float	88.53M	Perf Month	1.65%
Income	-32.56M	PEG	-	EPS next Q	0.03	Inst Own	76.92%	Short Float	12.63%	Perf Quarter	53.05%
Sales	742.53M	P/S	3.98	EPS this Y	134.64%	Inst Trans	2.06%	Short Ratio	6.69	Perf Half Y	52.86%
Book/sh	2.80	P/B	8.78	EPS next Y	37.72%	ROA	-5.37%	Short Interest	11.18M	Perf Year	89.22%
Cash/sh	2.09	P/C	11.78	EPS next 5Y	-	ROE	-10.15%	52W Range	11.35 - 27.10	Perf YTD	1.53%
Dividend Est.	-	P/FCF	90.70	EPS past 5Y	-1.04%	ROI	-6.42%	52W High	-9.30%	Beta	1.88
Dividend TTM	-	Quick Ratio	2.04	Sales past 5Y	16.55%	Gross Margin	53.80%	52W Low	116.56%	ATR (14)	1.13
Dividend Ex-Date	-	Current Ratio	2.44	EPS Y/Y TTM	50.53%	Oper. Margin	-5.69%	RSI (14)	49.07	Volatility	4.92% 4.56%
Employees	3491	Debt/Eq	0.58	Sales Y/Y TTM	13.47%	Profit Margin	-4.39%	Recom	2.00	Target Price	24.00
Option/Short	Yes / Yes	LT Debt/Eq	0.51	EPS Q/Q	77.17%	Payout	-	Rel Volume	1.54	Prev Close	26.22
Sales Surprise	1.21%	EPS Surprise	34.23%	Sales Q/Q	13.30%	Earnings	Nov 07 BMO	Avg Volume	1.67M	Price	24.58
SMA20	-2.69%	SMA50	4.30%	SMA200	42.13%	Trades		Volume	2,568,537	Change	-6.25%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-17-25	Downgrade	Evercore ISI	Outperform → In-line	$23
Nov-19-24	Reiterated	Telsey Advisory Group	Outperform	$22 → $26
Nov-08-24	Reiterated	Telsey Advisory Group	Outperform	$19 → $22
Nov-07-24	Upgrade	William Blair	Mkt Perform → Outperform
Oct-21-24	Upgrade	Goldman	Neutral → Buy	$15 → $18
Aug-23-24	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform	$20
Aug-23-24	Resumed	Piper Sandler	Overweight	$18
Oct-12-23	Upgrade	BTIG Research	Neutral → Buy	$17
Oct-03-23	Upgrade	Evercore ISI	In-line → Outperform	$20
Sep-25-23	Initiated	UBS	Neutral	$13
Jun-27-23	Initiated	William Blair	Mkt Perform
May-24-23	Initiated	JMP Securities	Mkt Perform
Mar-01-23	Downgrade	Citigroup	Buy → Neutral	$26 → $13
Feb-07-23	Initiated	BTIG Research	Neutral
Dec-15-22	Initiated	Wolfe Research	Outperform	$20
Jul-22-22	Initiated	Piper Sandler	Overweight	$20
May-18-22	Downgrade	Goldman	Buy → Neutral	$34 → $18
Mar-31-22	Initiated	Stifel	Hold	$36
Oct-26-21	Initiated	Citigroup	Buy	$67
Oct-25-21	Initiated	Telsey Advisory Group	Outperform	$66

Show Previous Ratings

Jan-02-25 11:52AM	The 4 S's driving retail success in 2025: Expert (Yahoo Finance Video)
Dec-17-24 02:58PM	Is Warby Parker Inc. (WRBY) Among Billionaire Daniel Sundheims Stock Picks Heading Into 2025? (Insider Monkey)
Dec-02-24 04:05PM	Warby Parker Announces Participation in the Morgan Stanley Global Consumer and Retail Conference (Business Wire)
04:05PM	Warby Parker Announces Participation in the Morgan Stanley Global Consumer & Retail Conference (Business Wire)
Nov-25-24 05:30AM	These Bricks-and-Mortar Stores Thrive in an Online World (The Wall Street Journal)
09:00AM	Loading…
Nov-15-24 09:00AM	Emma Chamberlain Embraces Retro Inspiration for Second Warby Parker Collection (WWD)
Nov-08-24 05:45AM	Warby Parker (WRBY) Q3 2024 Earnings Call Transcript (Motley Fool)
02:11AM	Warby Parker Inc (WRBY) Q3 2024 Earnings Call Highlights: Strong Retail Growth and Strategic ... (GuruFocus.com)
Nov-07-24 09:30AM	Compared to Estimates, Warby Parker (WRBY) Q3 Earnings: A Look at Key Metrics (Zacks)
08:00AM	Warby Parker Inc. (WRBY) Q3 Earnings Match Estimates (Zacks)
07:35AM	Warby Parker raises full-year guidance as it posts double-digit revenue growth in Q3 (Retail Dive)
06:45AM	Warby Parker Announces Third Quarter 2024 Results (Business Wire)
Nov-06-24 07:15AM	Warby Parker Inc (WRBY) Q3 2024 Earnings Report Preview: What to Expect (GuruFocus.com)
Nov-01-24 12:54PM	First Look: First Look: Warby Parker's redesigned SoHo store is rich in art (Chain Store Age)
Oct-21-24 04:03PM	Goldman Sachs upgrades Warby Parker to Buy on margin growth (Yahoo Finance Video) +9.97%
10:47AM	Loading…
10:47AM	Warby Parker Upgraded to Buy: Goldman Sachs Sees Growth Potential and Margin Expansion (GuruFocus.com)
Oct-17-24 07:00AM	Warby Parker to Announce Third Quarter 2024 Financial Results November 7, 2024 (Business Wire)
Oct-09-24 05:33PM	Warby Parker Inc (WRBY) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Oct-05-24 11:09AM	The big winner if OpenAI becomes a for-profit business? Microsoft. (Yahoo Finance)
Sep-29-24 02:26PM	Warby Parker founders on the key to their $1.8 billion success: Being nice guys (Fortune)
Sep-18-24 10:34AM	Factors That Lifted Warby Parker (WRBY) in Q2 (Insider Monkey)
Sep-13-24 07:01PM	Warby Parker Inc (WRBY) CFO Steven Miller Sells 6,763 Shares (GuruFocus.com)
Sep-12-24 01:19AM	Vanguard Group Inc's Strategic Acquisition of Warby Parker Inc Shares (GuruFocus.com)
Sep-03-24 08:00AM	Warby Parker Announces Participation in the Goldman Sachs 31st Annual Global Retailing Conference (Business Wire) -6.77%
Aug-29-24 06:01AM	How Warby Parker built a $1.8 billion brand without ever changing the original glasses price (Fortune)
Aug-09-24 07:06AM	Warby Parker notches highest e-commerce growth in 13 quarters (Retail Dive) -6.27%
Aug-08-24 03:45PM	Warby Parker (WRBY) Q2 2024 Earnings Call Transcript (Motley Fool)
02:03PM	Making sense of jobless claims, CEOs report Q2 success: Wealth! (Yahoo Finance Video)
09:30AM	Warby Parker (WRBY) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
07:55AM	Warby Parker Inc. (WRBY) Beats Q2 Earnings and Revenue Estimates (Zacks)
06:45AM	Loading…
06:45AM	Warby Parker Announces Second Quarter 2024 Results (Business Wire)
Aug-01-24 04:15PM	Warby Parker appoints Ronald A. Williams as Lead Director and welcomes Bradley E. Singer to Board of Directors (Business Wire)
Jul-18-24 07:00AM	Warby Parker to Announce Second Quarter 2024 Financial Results on August 8, 2024 (Business Wire)
Jun-27-24 10:36AM	Warby Parkers co-CEOs explain how they manage their successful partnership (Fortune)
Jun-07-24 01:01PM	Baillie Gifford Reduces Stake in Warby Parker Inc (GuruFocus.com)
Jun-05-24 08:36PM	Why Warby Parker Rallied Over 50% in May (Motley Fool)
Jun-01-24 06:44AM	Shop for Profits: 3 Retail Stocks That Are Adapting and Succeeding in 2024 (InvestorPlace)
May-31-24 07:30AM	Warby Parker Announces Participation in the TD Cowen 8th Annual Future of the Consumer Conference (Business Wire)
May-27-24 12:20PM	Earnings Estimates Moving Higher for Warby Parker (WRBY): Time to Buy? (Zacks)
12:00PM	Warby Parker Inc. (WRBY) is a Great Momentum Stock: Should You Buy? (Zacks)
May-26-24 08:02AM	Digital Brands Group, Inc. (NASDAQ:DBGI) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-16-24 05:23PM	Stanley Druckenmiller Bet On Biotech, Financial Services in Q1, Trimmed Nvidia Stake (Investopedia)
May-13-24 01:19PM	Warby Parker's CEOs, Roaring Kitty's Return, (CNBC TV)
10:18AM	Warby Parker co-CEO on tech in eyeglasses (CNBC TV)
09:18AM	Warby Parker co-CEOs on expansion strategy: Vast majority of Americans want to go into a store (CNBC TV)
May-10-24 03:42PM	Warby Parker narrows Q1 loss amid revenue growth; on track to open 40 stores (Chain Store Age)
02:33PM	Warby Parker Inc. (NYSE:WRBY) Q1 2024 Earnings Call Transcript (Insider Monkey)
01:33PM	Warby Parker Guidance Achievable, Path Still Uncertain, Morgan Stanley Says (MT Newswires)
01:30PM	Warby Parker Q1 2024 Earnings: Revenue Surges, Beats Estimates (GuruFocus.com)
11:08AM	UBS Boosts Price Target on Warby Parker to $15 From $13, Keeps Neutral Rating (MT Newswires)
06:48AM	Morgan Stanley Lifts Price Target on Warby Parker to $14 From $13, Keeps Equalweight Rating (MT Newswires)
12:58AM	Q1 2024 Warby Parker Inc Earnings Call (Thomson Reuters StreetEvents)
May-09-24 10:45PM	Warby Parker (WRBY) Q1 2024 Earnings Call Transcript (Motley Fool) +18.01%
12:47PM	Why Warby Parker Stock Was Climbing Today (Motley Fool)
09:45AM	Warby Parker's Q1 Net Loss Narrows as Revenue Increases; 2024 Revenue Guidance Boosted -- Shares Surge (MT Newswires)
09:30AM	Warby Parker (WRBY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
08:51AM	Warby Parker Posts Narrower Loss In Q1, Net Revenue Up 16.3%; Increases 2024 Guidance (RTT News)
08:47AM	Warby Parker narrows losses in Q1 as it posts 16.3% revenue growth (Retail Dive)
06:45AM	Warby Parker Announces First Quarter 2024 Results (Business Wire)
May-01-24 11:10AM	The Macerich Company (NYSE:MAC) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-18-24 04:05PM	Warby Parker to Announce First Quarter 2024 Financial Results on May 9, 2024 (Business Wire)
Apr-17-24 09:00AM	Warby Parker Publishes 2023 Impact Report (Business Wire)
Mar-20-24 10:09AM	Warby Parker Collaborates on Sunglasses Inspired by Theophilios Childhood in Jamaica (WWD)
Mar-08-24 11:54PM	Warby Parker Inc Co-CEO David Gilboa Sells 80,376 Shares (GuruFocus.com)
Mar-06-24 11:30PM	Warby Parker Inc CFO Steven Miller Sells 8,963 Shares (GuruFocus.com)
Mar-05-24 10:55AM	Warby Parker Inc. (NYSE:WRBY) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-29-24 04:47PM	Warby Parker to open 40 stores in 2024; add more higher-priced frames (Chain Store Age)
Feb-28-24 11:16PM	Q4 2023 Warby Parker Inc Earnings Call (Thomson Reuters StreetEvents) -14.96%
07:15PM	Warby Parker was gifted with a 40% lift in holiday traffic (Chain Store Age)
04:30PM	Warby Parker (WRBY) Q4 2023 Earnings Call Transcript (Motley Fool)
12:11PM	Warby Parker shares drop on pressured margins in Q4 (Yahoo Finance Video)
10:30AM	Warby Parker Looks to Open 40 Stores in 2024, Launch More Higher-priced Collections (WWD)
09:30AM	Warby Parker Inc. (WRBY) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
07:13AM	Warby Parker Inc (WRBY) Posts 12% Revenue Growth in 2023 Amid Expansion Efforts (GuruFocus.com)
07:10AM	Warby Parker eyes 40 new stores as it closes 2023 with revenue up 12% (Retail Dive)
06:49AM	Warby Parker Announces Fourth Quarter and Full Year 2023 Results (Business Wire)
Feb-08-24 04:05PM	Warby Parker to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 (Business Wire)
Jan-27-24 01:02PM	Baillie Gifford Bolsters Position in Warby Parker Inc (GuruFocus.com)
Jan-22-24 02:29PM	My 3 Favorite Stocks to Buy Right Now (Motley Fool)
Jan-15-24 05:30AM	Shoppers Prefer Staying Outdoors. Thats More Trouble for Malls. (The Wall Street Journal)
Dec-13-23 09:36PM	Warby Parker Inc CFO Steven Miller Sells 29,310 Shares (GuruFocus.com) +5.02%
Dec-10-23 06:30AM	Buy Your Glasses at Warby Parker? Beware This Pitfall (Motley Fool)
Dec-04-23 07:00AM	Warby Parker Announces Participation in the Morgan Stanley Global Consumer & Retail Conference (Business Wire)
Nov-10-23 04:03PM	Warby Parker Inc. (NYSE:WRBY) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 04:17PM	Why Warby Parker Plunged Today (Motley Fool) -23.99% -6.53%
03:11PM	Warby Parker Inc (WRBY) Reports Growth Amidst Market Headwinds (GuruFocus.com)
01:15PM	Warby Parker (WRBY) Q3 2023 Earnings Call Transcript (Motley Fool)
09:30AM	Warby Parker Inc. (WRBY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
08:03AM	Warby Parker opened 11 new stores in Q3, raises full-year guidance (Retail Dive)
06:45AM	Warby Parker Announces Third Quarter 2023 Results (Business Wire)
Oct-18-23 04:05PM	Warby Parker to Announce Third Quarter 2023 Financial Results on November 8, 2023 (Business Wire)
Oct-12-23 09:49AM	Target upgraded, Beyond Meat downgraded: Wall Street's top analyst calls (The Fly)
Oct-03-23 10:27AM	Evercore ISI Is Pounding the Table on Warby Parker (WRBY) Stock (InvestorPlace)
09:54AM	HP Inc. upgraded, Airbnb downgraded: Wall Street's top analyst calls (The Fly)
09:45AM	Warby Parker stock jumps on upgrade (Yahoo Finance Video)
01:18AM	HP snags surprise double upgrade at BofA: 6 big analyst picks (Investing.com)
Sep-07-23 04:05PM	Warby Parker Announces Participation in the Goldman Sachs 30th Annual Global Retailing Conference (Business Wire)
Aug-27-23 08:00AM	3 Stocks Ready to Bounce Back (Motley Fool)
Aug-23-23 09:02PM	Durable Capital Partners LP Reduces Stake in Warby Parker Inc (GuruFocus.com) -6.08%
Aug-20-23 10:00AM	Looking for an Alternative to ESG Investing? Heres One Possibility (The Wall Street Journal)

Warby Parker, Inc. operates as an online retailer of eyewear for men and women. It engages in the business of selling eyewear products and providing optical services directly to consumers through its retail stores and e-commerce platform. Its products include eyeglasses, sunglasses and contacts. The company was founded by Neil Blumenthal, Andrew Martin Hunt, Jeffrey J. Raider and David Gilboa on May 7, 2010 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sulzberger Gabrielle	Officer	Jan 10 '25	Proposed Sale	26.50	36,942	978,963		Jan 10 04:31 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Jan 02 '25	Sale	25.14	300,000	7,542,000	12,177	Jan 06 06:16 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jan 02 '25	Sale	25.14	338,004	8,497,447	12,306	Jan 06 06:15 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jan 03 '25	Sale	25.41	36,996	940,068	12,306	Jan 06 06:15 PM
DAVID GILBOA	Director	Jan 02 '25	Proposed Sale	24.21	550,000	13,315,500		Jan 02 04:24 PM
NEIL BLUMENTHAL	Director	Jan 02 '25	Proposed Sale	24.21	450,000	10,894,500		Jan 02 04:22 PM
Gilboa David Abraham	Co-Chief Executive Officer	Dec 20 '24	Sale	25.11	144,212	3,621,163	12,306	Dec 26 05:00 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Dec 20 '24	Sale	25.08	93,946	2,356,166	12,177	Dec 26 05:00 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Dec 18 '24	Sale	25.09	56,054	1,406,395	12,177	Dec 20 05:01 PM
Gilboa David Abraham	Co-Chief Executive Officer	Dec 18 '24	Sale	25.09	55,788	1,399,721	12,306	Dec 20 05:00 PM
DAVID ABRAHAM GILBOA	Director	Dec 18 '24	Proposed Sale	24.29	200,000	4,858,000		Dec 18 04:27 PM
NEIL HARRIS BLUMENTHAL	Director	Dec 18 '24	Proposed Sale	24.29	150,000	3,643,500		Dec 18 04:26 PM
Miller Steven Clive	Chief Financial Officer	Dec 11 '24	Sale	23.85	7,016	167,332	182,130	Dec 13 06:20 PM
Gilboa David Abraham	Co-Chief Executive Officer	Dec 10 '24	Sale	23.50	304,947	7,166,254	12,306	Dec 12 06:25 PM
Gilboa David Abraham	Co-Chief Executive Officer	Dec 11 '24	Sale	23.84	54,000	1,287,360	12,306	Dec 12 06:25 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Dec 09 '24	Sale	23.65	50,000	1,182,500	12,177	Dec 11 05:42 PM
STEVE MILLER	Officer	Dec 11 '24	Proposed Sale	23.53	7,016	165,086		Dec 11 05:03 PM
DAVID ABRAHAM GILBOA	Director	Dec 11 '24	Proposed Sale	23.53	54,000	1,270,620		Dec 11 04:54 PM
DAVID ABRAHAM GILBOA	Director	Dec 10 '24	Proposed Sale	23.50	304,947	7,166,254		Dec 10 04:25 PM
NEIL BLUMENTHAL	Director	Dec 09 '24	Proposed Sale	23.79	50,000	1,189,500		Dec 09 04:45 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Dec 03 '24	Sale	22.61	36,163	817,645	12,177	Dec 05 07:40 PM
Miller Steven Clive	Chief Financial Officer	Dec 03 '24	Option Exercise	0.00	26,511	0	203,999	Dec 05 07:39 PM
Miller Steven Clive	Chief Financial Officer	Dec 03 '24	Sale	22.61	14,853	335,826	189,146	Dec 05 07:39 PM
Gilboa David Abraham	Co-Chief Executive Officer	Dec 03 '24	Sale	22.61	36,163	817,645	12,306	Dec 05 07:37 PM
Steven Clive Miller	Officer	Dec 03 '24	Proposed Sale	22.02	14,660	322,813		Dec 03 06:45 PM
Neil Harris Blumenthal	Director, Officer	Dec 03 '24	Proposed Sale	22.02	35,833	789,043		Dec 03 06:43 PM
David Abraham Gilboa	Director, Officer	Dec 03 '24	Proposed Sale	22.02	35,833	789,043		Dec 03 06:42 PM
Warby Parker Impact Foundation	Affiliate	Nov 14 '24	Proposed Sale	21.34	29,762	635,000		Nov 14 02:10 PM
Miller Steven Clive	Chief Financial Officer	Sep 11 '24	Sale	13.90	6,763	94,006	177,488	Sep 13 05:00 PM
STEVE MILLER	Officer	Sep 11 '24	Proposed Sale	13.88	6,763	93,870		Sep 11 04:18 PM
Miller Steven Clive	Chief Financial Officer	Sep 06 '24	Option Exercise	0.00	26,511	0	199,523	Sep 10 08:21 PM
Miller Steven Clive	Chief Financial Officer	Sep 06 '24	Sale	13.00	15,272	198,536	184,251	Sep 10 08:21 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Sep 09 '24	Sale	13.89	50,000	694,625	12,177	Sep 10 08:20 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Sep 06 '24	Sale	13.00	27,143	352,859	12,177	Sep 10 08:20 PM
Gilboa David Abraham	Co-Chief Executive Officer	Sep 10 '24	Sale	13.69	49,034	671,275	12,306	Sep 10 08:19 PM
Gilboa David Abraham	Co-Chief Executive Officer	Sep 06 '24	Sale	13.00	27,143	352,859	12,306	Sep 10 08:19 PM
DAVID GILBOA	Director	Sep 10 '24	Proposed Sale	13.91	49,034	682,063		Sep 10 04:22 PM
NEIL BLUMENTHAL	Director	Sep 09 '24	Proposed Sale	13.10	50,000	655,000		Sep 09 04:28 PM
David Abraham Gilboa	Director, Officer	Sep 06 '24	Proposed Sale	12.69	27,812	352,924		Sep 06 07:34 PM
Steven Clive Miller	Officer	Sep 06 '24	Proposed Sale	12.69	15,643	198,504		Sep 06 07:33 PM
Neil Harris Blumenthal	Director, Officer	Sep 06 '24	Proposed Sale	12.69	27,812	352,924		Sep 06 07:28 PM
SINGER BRADLEY E	Director	Aug 13 '24	Buy	13.00	50,000	650,000	100,000	Aug 14 04:52 PM
SINGER BRADLEY E	Director	Aug 14 '24	Buy	12.63	25,000	315,750	125,000	Aug 14 04:52 PM
D1 Capital Partners L.P.	10% Owner	Jun 14 '24	Sale	15.66	5,500,000	86,130,000	9,444,023	Jun 18 04:15 PM
Briggs Teresa	Director	Jun 13 '24	Sale	16.31	7,396	120,629	38,859	Jun 17 05:04 PM
Miller Steven Clive	Chief Financial Officer	Jun 12 '24	Option Exercise	13.35	99,816	1,332,544	272,828	Jun 13 05:26 PM
Miller Steven Clive	Chief Financial Officer	Jun 12 '24	Sale	16.61	99,816	1,657,944	173,012	Jun 13 05:26 PM
Miller Steven Clive	Chief Financial Officer	Jun 11 '24	Sale	16.59	9,394	155,846	173,012	Jun 13 05:26 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Jun 07 '24	Sale	16.65	76,582	1,275,122	12,177	Jun 11 09:54 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jun 10 '24	Sale	16.69	149,034	2,487,377	12,306	Jun 11 09:29 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jun 07 '24	Sale	16.67	26,582	443,122	12,306	Jun 11 09:29 PM
Miller Steven Clive	Chief Financial Officer	Jun 07 '24	Option Exercise	12.35	58,455	721,919	225,334	Jun 10 08:02 PM
Miller Steven Clive	Chief Financial Officer	Jun 06 '24	Option Exercise	13.04	11,263	146,837	182,588	Jun 10 08:02 PM
Miller Steven Clive	Chief Financial Officer	Jun 07 '24	Sale	16.54	69,439	1,148,429	166,879	Jun 10 08:02 PM
Miller Steven Clive	Chief Financial Officer	Jun 06 '24	Sale	17.04	15,709	267,619	166,879	Jun 10 08:02 PM
Miller Steven Clive	Chief Financial Officer	Mar 11 '24	Sale	11.98	24,225	290,216	166,879	Mar 13 04:33 PM
Gilboa David Abraham	Co-Chief Executive Officer	Mar 08 '24	Sale	12.20	52,065	635,193	12,306	Mar 08 06:19 PM
Gilboa David Abraham	Co-Chief Executive Officer	Mar 06 '24	Sale	11.88	28,311	336,335	12,306	Mar 08 06:19 PM
Miller Steven Clive	Chief Financial Officer	Mar 06 '24	Option Exercise	0.00	21,159	0	199,812	Mar 08 06:18 PM
Miller Steven Clive	Chief Financial Officer	Mar 06 '24	Sale	11.88	8,708	103,451	191,104	Mar 08 06:18 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Mar 07 '24	Sale	12.40	50,000	620,000	12,177	Mar 08 06:16 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Mar 06 '24	Sale	11.88	28,311	336,335	12,177	Mar 08 06:16 PM
Miller Steven Clive	Chief Financial Officer	Mar 05 '24	Sale	12.12	8,963	108,632	178,653	Mar 06 05:08 PM
Gilboa David Abraham	Co-Chief Executive Officer	Mar 05 '24	Sale	12.12	16,731	202,780	12,306	Mar 06 05:07 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Mar 05 '24	Sale	12.12	16,731	202,780	12,177	Mar 06 05:05 PM

Dollar change -0.01
Percentage change -0.17	%

LUCY Innovative Eyewear Inc daily Stock Chart

Peers: SONY LOGI GRMN BBY VSTO TBCH BB KOSS NTGR UEIC

| Held by: VXF DFAT

Index	-	P/E	-	EPS (ttm)	-9.61	Insider Own	51.59%	Shs Outstand	2.42M	Perf Week	4.80%
Market Cap	14.38M	Forward P/E	-	EPS next Y	-2.71	Insider Trans	113.11%	Shs Float	1.18M	Perf Month	-9.66%
Income	-8.03M	PEG	-	EPS next Q	-1.16	Inst Own	3.41%	Short Float	2.30%	Perf Quarter	-16.81%
Sales	1.56M	P/S	9.22	EPS this Y	44.84%	Inst Trans	-44.96%	Short Ratio	0.10	Perf Half Y	-5.00%
Book/sh	4.52	P/B	1.30	EPS next Y	61.61%	ROA	-81.51%	Short Interest	0.03M	Perf Year	-30.62%
Cash/sh	3.87	P/C	1.52	EPS next 5Y	-	ROE	-86.51%	52W Range	3.26 - 27.20	Perf YTD	19.72%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-73.50%	52W High	-78.35%	Beta	2.65
Dividend TTM	-	Quick Ratio	15.22	Sales past 5Y	393.99%	Gross Margin	-3.76%	52W Low	80.67%	ATR (14)	0.52
Dividend Ex-Date	-	Current Ratio	16.83	EPS Y/Y TTM	32.94%	Oper. Margin	-528.11%	RSI (14)	50.00	Volatility	6.41% 8.66%
Employees	11	Debt/Eq	0.00	Sales Y/Y TTM	158.62%	Profit Margin	-514.51%	Recom	1.00	Target Price	14.00
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	58.75%	Payout	-	Rel Volume	0.07	Prev Close	5.90
Sales Surprise	-71.82%	EPS Surprise	27.21%	Sales Q/Q	14.30%	Earnings	Nov 13 BMO	Avg Volume	258.99K	Price	5.89
SMA20	4.72%	SMA50	-6.85%	SMA200	-10.78%	Trades		Volume	18,570	Change	-0.17%

Jan-16-25 08:30AM	Innovative Eyewear Announces Lucyd Armor Safety Certification for Canada (PR Newswire)
Jan-15-25 08:30AM	Innovative Eyewear Announces Participation in Key Industry Events in Q1 2025 (PR Newswire)
Dec-16-24 10:55PM	New to the Street Show #617 Airs Tonight on Fox Business at 10:30 PM PST as Sponsored Programming (ACCESS Newswire) +6.71% -7.82%
Nov-25-24 08:30AM	Innovative Eyewear Launches Four New Lucyd Lyte Smart Glasses with Enhanced Features (PR Newswire)
Nov-13-24 08:00AM	Innovative Eyewear Inc. Reports Third Quarter 2024 Financial Results (PR Newswire)
08:30AM	Loading…
Nov-05-24 08:30AM	Innovative Eyewear, Inc. Announces Lucyd Smart Eyewear Now Sold at Nebraska Furniture Mart (PR Newswire)
Oct-29-24 08:30AM	Innovative Eyewear Launches First ANSI-Certified Smart Safety Glasses for All-day Wear (PR Newswire) +28.93%
Oct-24-24 08:30AM	Innovative Eyewear, Inc. Announces Notice of Patent Allowance on Modular Smart Eyewear Technology (PR Newswire) -5.40%
Oct-14-24 08:30AM	Innovative Eyewear Launches First-Ever Generative AI Eyewear Fashion Show (PR Newswire)
Oct-02-24 12:07PM	Innovative Eyewear Announces New Retail Partners (PR Newswire) +18.67%
Sep-25-24 08:20PM	Innovative Eyewear, Inc. Adopts Limited Duration Stockholders Rights Plan (PR Newswire) -9.46%
Sep-23-24 08:00AM	Innovative Eyewear, Inc. Announces Exercise of Warrants for $2.6 Million Gross Proceeds (PR Newswire) -16.13%
Sep-17-24 08:30AM	Innovative Eyewear to Unveil ANSI-Certified Smart Safety Eyewear at Vision Expo West (PR Newswire) +25.00%
Sep-05-24 08:30AM	Innovative Eyewear Secures Distribution Deal for Gulf Cooperation Council (GCC) Countries (PR Newswire)
Sep-04-24 05:49PM	Innovative Eyewear, Inc. Announces Closing of Exercise of Warrants (PR Newswire) +5.35%
08:39AM	Loading…
Sep-03-24 08:39AM	Innovative Eyewear, Inc. Announces Exercise of Warrants (PR Newswire) -10.74%
Aug-29-24 08:00AM	Innovative Eyewear, Inc. Announces Lucyd Smart Eyewear Now Sold on Target.com (PR Newswire) +53.78%
Aug-21-24 08:00AM	Innovative Eyewear, Inc. Announces Strategic Alliance with Geenee Inc. to Deliver Next-gen Smart Eyewear Retail Experiences (PR Newswire)
Aug-13-24 08:00AM	Innovative Eyewear Inc. Reports Second Quarter 2024 Financial Results (PR Newswire) +13.33%
Aug-01-24 10:22AM	Innovative Eyewear Inc. Regains Compliance with Nasdaq Listing Requirements (Newsfile)
Jul-18-24 08:00AM	Innovative Eyewear Inc. Announces the First Walkie-Talkie Feature for Smart Eyewear (Newsfile) -16.53%
Jun-14-24 08:30AM	Innovative Eyewear Inc. Announces Significant Progress in International Expansion (PR Newswire)
Jun-13-24 08:30AM	Innovative Eyewear, Inc. Launches Bixby App to Enable ChatGPT on its Smart Eyewear (PR Newswire) -12.89%
Jun-07-24 06:40AM	7 Growth Stocks to Buy in June for Great Gains (InvestorPlace) -11.12%
Jun-03-24 08:00AM	Innovative Eyewear, Inc. to Participate in 'Charting the Course: Navigating the Intersection of TMT and Business in the AI Era' Conference, June 4 - 5, 2024 (PR Newswire)
May-30-24 07:47AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) -16.75%
May-29-24 04:15PM	Innovative Eyewear, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (PR Newswire) +131.46%
12:15PM	PLTR Stock Alert: Palantir Strikes New Deal With Eaton (InvestorPlace)
11:58AM	Why Is Innovative Eyewear (LUCY) Stock Up 188% Today? (InvestorPlace)
09:00AM	Innovative Eyewear, Inc. Launches Eddie Bauer Smart Eyewear with ChatGPT (PR Newswire)
07:39AM	Loading…
07:39AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
May-28-24 02:43PM	Innovative Eyewear, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (PR Newswire) -58.29%
07:27AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
May-24-24 04:02PM	What's Going on With Innovative Eyewear (LUCY) Stock Today? (InvestorPlace) +428.49%
07:16AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
May-14-24 01:53PM	LUCY Stock Earnings: Innovative Eyewear Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace) +7.93%
08:30AM	Innovative Eyewear Inc. Reports First Quarter 2024 Financial Results (PR Newswire)
May-01-24 05:00PM	Innovative Eyewear, Inc. Announces Closing of $1.025 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules (PR Newswire) +9.04%
04:30PM	7 Penny Stocks With the Potential to Make You an Overnight Millionaire (InvestorPlace)
Apr-29-24 08:00AM	Innovative Eyewear, Inc. Announces $1.025 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (PR Newswire)
Apr-25-24 08:32AM	Innovative Eyewear, Inc. Partners with New Look Vision Group to Provide Smart Eyewear in Canada (PR Newswire)
Apr-24-24 08:30AM	Innovative Eyewear, Inc. Announces New Patent Filings and Receipt of Notices of Allowance on Smart Safety Eyewear (PR Newswire)
Apr-18-24 08:30AM	Innovative Eyewear, Inc. Signs UK Football Legend and Media Personality Micah Richards as Brand Ambassador (PR Newswire)
Apr-17-24 08:30AM	Innovative Eyewear, Inc. Signs Distribution Partnership with Windsor Eyes, Inc. (PR Newswire)
Mar-25-24 01:53PM	LUCY Stock Earnings: Innovative Eyewear Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
08:30AM	Innovative Eyewear Inc. Reports 2023 Financial Results (PR Newswire)
Feb-01-24 09:00AM	Innovative Eyewear, Inc. Commences Shipping of Nautica Smart Eyewear Collection (PR Newswire)
Jan-22-24 08:00AM	Diamond Equity Research to Host Spotlight Emerging Growth Invitational Virtual Investor Conference on January 23, 2024 (GlobeNewswire)
Jan-11-24 08:00AM	Innovative Eyewear, Inc. 2023 Year-end Review (PR Newswire) -8.67%
Jan-10-24 08:00AM	Innovative Eyewear, Inc. Receives Notice of Allowance for Fourteen Patent Applications (PR Newswire) +6.06%
Jan-05-24 10:04AM	Innovative Eyewear, Inc. and IngenioSpec LLC Announce License Agreement (PR Newswire) -6.84%
Dec-14-23 08:30AM	Innovative Eyewear, Inc. Signs Professional Football Player Emmanuel Ogbah as Brand Ambassador (PR Newswire) -9.50%
Dec-13-23 09:00AM	Global Smart Eyewear Market Size Expected to Reach $10.6 Billion By 2024 (PR Newswire)
Dec-12-23 08:30AM	Innovative Eyewear, Inc. Announces the 2.0 Release of its Android ChatGPT App for Smart Eyewear (PR Newswire) -10.80%
Dec-11-23 08:30AM	Innovative Eyewear, Inc. Launches Nautica Smart Eyewear Under Multi-Year, Global Licensing Agreement with Authentic Brands Group (PR Newswire) +11.11%
Nov-16-23 07:00AM	Innovative Eyewear, Inc. Launches Upgraded Charging Dock for ChatGPT-enabled Smart Eyewear (PR Newswire)
Oct-17-23 07:00AM	Innovative Eyewear, Inc. Launches the Lyte XL Smart Eyewear Collection (PR Newswire) +12.69%
Oct-03-23 08:00AM	Innovative Eyewear, Inc. (Nasdaq: LUCY) to Present at 8th Annual Dawson James Conference (GlobeNewswire) -6.04%
Sep-22-23 03:05PM	Maxim Group LLC to Host the Virtual Tech Conference Series: Emerging Growth in A.I., on Tuesday, September 26th & Wednesday, September 27th at 8:00 A.M. ET. (GlobeNewswire)
Sep-21-23 09:35AM	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference (GlobeNewswire)
Sep-11-23 07:00AM	Innovative Eyewear, Inc. Announces New Patent Filing on Self-adjusting Spring Hinges for Smartglasses (PR Newswire) +8.40%
Aug-15-23 10:20AM	Sidoti Events, LLCs Virtual August Micro-Cap Conference (ACCESSWIRE)
Aug-14-23 07:00AM	Innovative Eyewear, Inc. Announces the 2.0 Release of its ChatGPT App for Smart Eyewear (PR Newswire)
Aug-03-23 09:25AM	Innovative Eyewear, Inc. Interim Company Update (GlobeNewswire)
08:30AM	Innovative Eyewear Discusses Smart Eyewear Market, Product Differentiation, Brand Partnerships and Value Catalysts in New CEO Video Interview on Planet MicroCap (ACCESSWIRE)
08:00AM	Harrison Gross CEO, Innovative Eyewear Inc. Discusses Smart Eyewear a Recent Partnership, and More with Steve Macalbry of BestGrowthStocks.Com (News Direct)
Aug-02-23 02:26PM	Innovative Eyewear CEO says company is leading innovation in smart eyewear; unveils new Blueshift Lens (News Direct)
Aug-01-23 08:00AM	Innovative Eyewear, Inc. Launches the Lucyd Blueshift Lens for Enhanced Eye Protection and Comfort (PR Newswire)
Jun-30-23 07:00AM	Innovative Eyewear, Inc. Announces Miami Swim Week Runway Show and New Summer Lens Collection (PR Newswire)
Jun-28-23 07:00AM	Innovative Eyewear, Inc. Announces Partnership with PRIVATO Duty Free (PR Newswire)
Jun-26-23 02:44PM	Innovative Eyewear Announces Closing of $4.7 Million Public Offering (PR Newswire)
Jun-22-23 08:15AM	Innovative Eyewear Announces Pricing of $4.7 Million Public Offering (GlobeNewswire) -27.34%
Jun-20-23 07:00AM	Innovative Eyewear, Inc. Announces Multi-Year, Global Licensing Agreement With Authentic Brands Group for Reebok® Smart Eyewear (PR Newswire) -10.96%
May-09-23 07:15AM	Sidoti's Micro-Cap Virtual May Conference (ACCESSWIRE) -10.00%
Apr-14-23 07:00AM	Innovative Eyewear Inc. Hosts Its First Smart Eyewear Fashion Show in Miami to Introduce Lucyd® Lyte 2.0 Collection With ChatGPT Integration (PR Newswire)
Apr-12-23 08:52AM	Is Innovative Eyewear (NASDAQ:LUCY) In A Good Position To Invest In Growth? (Simply Wall St.)
07:00AM	Innovative Eyewear, Inc. Files Patent For ChatGPT Enabled Smart Eyewear (PR Newswire)
Apr-11-23 07:00AM	Innovative Eyewear, Inc. Launches The First ChatGPT Enabled Smart Eyewear (PR Newswire) +201.37%
Mar-02-23 07:00AM	Innovative Eyewear, Inc. Launches New Titanium Styles of Lucyd Lyte® 2.0 Audio Eyewear (PR Newswire)
Feb-23-23 11:18AM	Innovative Eyewear Inc. Launches Lucyd Lyte 2.0 the Next Generation of Smart Eyewear on Amazon (PR Newswire)
Feb-07-23 02:00AM	Innovative Eyewear, Inc. Launches Lucyd Lyte 2.0 Audio Eyewear Line (PR Newswire) +22.35%
Feb-06-23 02:00AM	Innovative Eyewear, Inc. Announces Features Update for its Vyrb Social Audio App (PR Newswire) +9.91%
Dec-28-22 07:00AM	Innovative Eyewear, Inc. Announces Multi-Year, Global Licensing Agreement with Authentic Brands Group for Eddie Bauer® Smart Eyewear (GlobeNewswire) +38.99%
Dec-27-22 07:00AM	Innovative Eyewear, Inc. 2022 Year-end Review (GlobeNewswire) +6.76%
Nov-16-22 05:47AM	Innovative Eyewear Third Quarter 2022 Earnings: US$0.21 loss per share (vs US$0.18 loss in 3Q 2021) (Simply Wall St.) -6.57%
Oct-25-22 08:05AM	Traders News Source Senior Editor, Mark Roberts Interviews Harrison Gross, CEO & Director Innovative Eyewear, Inc. (ACCESSWIRE)
Oct-11-22 02:00AM	Innovative Eyewear, Inc. Announces Appointment of Sr. Vice President, Sales and Marketing and VP of Global Optical Sales and Marketing (GlobeNewswire) +20.37%
Oct-03-22 02:00AM	Innovative Eyewear, Inc. Announces Multi-Year, Global Licensing Agreement of the Nautica® brand for Smart Eyewear (GlobeNewswire) +13.67%
Aug-18-22 07:00AM	Innovative Eyewear Inc. Announces Debut of their Lucyd Lyte Fall '22 Collection (PR Newswire)
Aug-17-22 01:16PM	Innovative Eyewear, Inc. Announces Closing of $7.35 Million Initial Public Offering (PR Newswire)
Aug-14-22 06:35PM	Innovative Eyewear, Inc. Announces Pricing of $7.35 Million Initial Public Offering (PR Newswire)

Innovative Eyewear, Inc. retails eye glasses online. It designs and provides smart glasses enhanced with tech features such as built-in Bluetooth audio connectivity, phone control buttons and instant AI voice assistant access. The company was founded by Harrison Gross, Konrad Dabrowski and David Eric Cohen in 2019 and is headquartered in Miami, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Galkin Vladimir	10% Owner	Sep 23 '24	Buy	9.08	200,792	1,822,973	1,000,000	Sep 26 08:31 AM
Galkin Vladimir	10% Owner	Sep 20 '24	Buy	10.31	70,000	721,472	813,245	Sep 24 03:28 PM
Galkin Vladimir	10% Owner	Sep 20 '24	Sale	10.61	14,037	148,896	799,208	Sep 24 03:28 PM
Galkin Vladimir	10% Owner	Sep 19 '24	Buy	8.91	297,443	2,649,148	785,573	Sep 24 02:51 PM
Galkin Vladimir	10% Owner	Sep 19 '24	Sale	9.07	42,328	384,100	743,245	Sep 24 02:51 PM
Galkin Vladimir	10% Owner	Sep 18 '24	Buy	7.79	128,130	997,896	548,130	Sep 24 12:25 PM
Galkin Vladimir	10% Owner	Sep 18 '24	Sale	8.17	60,000	490,400	488,130	Sep 24 12:25 PM
Galkin Vladimir	10% Owner	Sep 17 '24	Buy	7.12	346,736	2,469,387	678,483	Sep 24 12:00 PM
Galkin Vladimir	10% Owner	Sep 17 '24	Sale	7.27	258,483	1,879,632	420,000	Sep 24 12:00 PM
Gross Harrison R.	Chief Executive Officer	Aug 19 '24	Buy	3.68	500	1,840	500	Aug 21 01:48 PM

Dollar change +1.23
Percentage change 1.34	%

COO Cooper Companies, Inc daily Stock Chart

Peers: ALGN SYK JNJ ISRG BSX ZBH MDT BAX HOLX STE

| Held by: VTI VOO VO SPY IVV RSP VOT XLV VUG VTV

Index	S&P 500	P/E	47.69	EPS (ttm)	1.96	Insider Own	0.58%	Shs Outstand	199.60M	Perf Week	3.28%
Market Cap	18.62B	Forward P/E	20.97	EPS next Y	4.45	Insider Trans	-18.13%	Shs Float	198.43M	Perf Month	-0.76%
Income	392.30M	PEG	4.54	EPS next Q	0.92	Inst Own	97.45%	Short Float	1.38%	Perf Quarter	-14.08%
Sales	3.90B	P/S	4.78	EPS this Y	7.95%	Inst Trans	-1.12%	Short Ratio	1.94	Perf Half Y	2.14%
Book/sh	40.50	P/B	2.30	EPS next Y	11.65%	ROA	3.27%	Short Interest	2.73M	Perf Year	-1.51%
Cash/sh	0.54	P/C	172.84	EPS next 5Y	10.50%	ROE	5.02%	52W Range	84.76 - 112.38	Perf YTD	1.46%
Dividend Est.	0.03 (0.03%)	P/FCF	64.61	EPS past 5Y	-3.45%	ROI	3.61%	52W High	-17.00%	Beta	1.00
Dividend TTM	-	Quick Ratio	1.12	Sales past 5Y	8.41%	Gross Margin	61.47%	52W Low	10.04%	ATR (14)	2.10
Dividend Ex-Date	Jul 26, 2023	Current Ratio	1.91	EPS Y/Y TTM	32.56%	Oper. Margin	18.12%	RSI (14)	48.58	Volatility	2.49% 2.08%
Employees	16000	Debt/Eq	0.35	Sales Y/Y TTM	8.41%	Profit Margin	10.07%	Recom	1.95	Target Price	115.00
Option/Short	Yes / Yes	LT Debt/Eq	0.34	EPS Q/Q	38.00%	Payout	0.00%	Rel Volume	1.38	Prev Close	92.04
Sales Surprise	-0.82%	EPS Surprise	3.98%	Sales Q/Q	9.85%	Earnings	Dec 05 AMC	Avg Volume	1.41M	Price	93.27
SMA20	1.48%	SMA50	-4.11%	SMA200	-4.04%	Trades		Volume	1,950,968	Change	1.34%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-29-24	Reiterated	Piper Sandler	Overweight	$115 → $120
Jul-16-24	Upgrade	Jefferies	Hold → Buy	$107 → $115
Mar-19-24	Upgrade	Redburn Atlantic	Neutral → Buy	$125
Mar-13-24	Upgrade	JP Morgan	Neutral → Overweight	$100 → $120
Feb-06-24	Resumed	KeyBanc Capital Markets	Sector Weight
Oct-30-23	Initiated	BofA Securities	Buy	$380
Oct-05-23	Downgrade	Redburn Atlantic	Overweight → Neutral	$390 → $343
May-30-23	Initiated	Morgan Stanley	Equal-Weight	$410
Dec-22-22	Initiated	Mizuho	Buy	$375
Nov-30-22	Upgrade	Robert W. Baird	Neutral → Outperform	$345 → $375
Oct-12-22	Downgrade	Jefferies	Buy → Hold	$400 → $295
Aug-29-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-17-22	Upgrade	Citigroup	Neutral → Buy	$460 → $405
Apr-08-22	Initiated	Needham	Hold
Jan-03-22	Upgrade	Guggenheim	Neutral → Buy
Sep-03-21	Reiterated	Stifel	Buy	$450 → $475
Sep-03-21	Reiterated	Oppenheimer	Perform	$405 → $475
Sep-03-21	Reiterated	KeyBanc Capital Markets	Overweight	$444 → $476
Sep-03-21	Reiterated	Citigroup	Neutral	$400 → $453
Apr-23-21	Initiated	Redburn	Buy

Show Previous Ratings

Jan-08-25 08:46AM	Are Options Traders Betting on a Big Move in Cooper Companies (COO) Stock? (Zacks)
Dec-17-24 04:15PM	CooperCompanies to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-13-24 07:36PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
Dec-09-24 09:15AM	The Cooper Companies (COO) International Revenue in Focus: Trends and Expectations (Zacks)
Dec-06-24 09:47AM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
08:16AM	Loading…
08:16AM	Q4 2024 CooperCompanies Inc Earnings Call (Thomson Reuters StreetEvents)
02:03AM	The Cooper Companies Inc (COO) Q4 2024 Earnings Call Highlights: Record Revenues and Strategic ... (GuruFocus.com)
Dec-05-24 07:00PM	The Cooper Companies (COO) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:25PM	The Cooper Companies (COO) Q4 Earnings Beat Estimates (Zacks)
04:34PM	The Cooper Companies: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:15PM	CooperCompanies Announces Fourth Quarter and Full Year 2024 Results (GlobeNewswire)
Dec-02-24 01:29PM	Unveiling The Cooper Companies (COO) Q4 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Nov-28-24 12:22PM	Meridian Growth Fund Trimmed The Cooper Companies (COO) For Valuation Discipline (Insider Monkey)
Nov-12-24 04:15PM	CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2024 (GlobeNewswire)
Oct-30-24 08:10AM	What Makes The Cooper Companies (COO) a Strong Investment? (Insider Monkey)
12:00PM	Loading…
Sep-19-24 12:00PM	The Cooper Companies (COO) is a Great Momentum Stock: Should You Buy? (Zacks)
Sep-12-24 09:55AM	After Golden Cross, The Cooper Companies (COO)'s Technical Outlook is Bright (Zacks)
Sep-10-24 04:28PM	CooperCompanies Recognized as a Best Workplace for Innovators (GlobeNewswire)
Sep-03-24 04:15PM	CooperSurgical Launches Paragard Intrauterine Copper Contraceptive with New Single-Hand Inserter (Business Wire)
Sep-02-24 09:15AM	A Dive into The Cooper Companies (COO) International Revenue Trends and Forecasts (Zacks)
Aug-30-24 01:24AM	Decoding The Cooper Companies Inc (COO): A Strategic SWOT Insight (GuruFocus.com)
Aug-29-24 06:35PM	Why Cooper Companies Stock Triumphed on Thursday (Motley Fool) +11.84%
11:06AM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
10:52AM	Q3 2024 Cooper Companies Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-28-24 06:00PM	Compared to Estimates, The Cooper Companies (COO) Q3 Earnings: A Look at Key Metrics (Zacks)
05:25PM	The Cooper Companies (COO) Q3 Earnings and Revenues Surpass Estimates (Zacks)
04:26PM	The Cooper Companies: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	CooperCompanies Announces Third Quarter 2024 Results (GlobeNewswire)
Aug-27-24 09:02AM	What To Expect From The Cooper Companies Inc (COO) Q3 2024 Earnings (GuruFocus.com)
Aug-26-24 12:10PM	Will The Cooper Companies (COO) Beat Estimates Again in Its Next Earnings Report? (Zacks)
08:28AM	Loading…
08:28AM	What's in Store for Cooper Companies (COO) in Q3 Earnings? (Zacks)
Aug-23-24 12:00PM	Reasons to Add The Cooper Companies (COO) to Your Portfolio Now (Zacks)
09:15AM	Unveiling The Cooper Companies (COO) Q3 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Aug-08-24 04:15PM	CooperCompanies to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-06-24 04:15PM	CooperCompanies Announces Release Date for Third Quarter 2024 (GlobeNewswire)
Aug-01-24 04:15PM	CooperCompanies Acquires obp Surgical, Expanding CooperSurgical's Portfolio of Leading Medical Devices (GlobeNewswire)
Jul-24-24 08:04AM	Reasons to Add The Cooper Companies (COO) to Your Portfolio Now (Zacks)
Jul-15-24 02:00AM	CooperVision Champions Children's Eye Health at WCPOS V 2024 (PR Newswire)
Jun-18-24 07:54AM	Reasons to Retain The Cooper Companies (COO) in Your Portfolio Now (Zacks)
Jun-01-24 01:04AM	Decoding The Cooper Companies Inc (COO): A Strategic SWOT Insight (GuruFocus.com)
May-31-24 11:41AM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
May-30-24 08:53PM	COO Stock Earnings: Cooper Companies Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
06:00PM	The Cooper Companies (COO) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:25PM	The Cooper Companies (COO) Surpasses Q2 Earnings Estimates (Zacks)
04:25PM	The Cooper Companies: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	CooperCompanies Announces Second Quarter 2024 Results (GlobeNewswire)
May-28-24 07:45PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
09:53AM	What's in Store for Cooper Companies (COO) in Q2 Earnings? (Zacks)
May-24-24 09:15AM	Insights Into The Cooper Companies (COO) Q2: Wall Street Projections for Key Metrics (Zacks)
May-23-24 04:15PM	CooperCompanies' 2023 Environmental, Social, and Governance Report Highlights Efforts that Benefit People and the Planet (GlobeNewswire)
May-20-24 03:57PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
May-15-24 07:54PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
04:15PM	CooperCompanies to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire)
May-14-24 04:15PM	CooperCompanies to Participate in the William Blair Growth Stock Conference (GlobeNewswire)
06:51AM	Reasons to Add The Cooper Companies (COO) to Your Portfolio (Zacks)
Apr-30-24 04:15PM	CooperCompanies Announces Release Date for Second Quarter 2024 (GlobeNewswire)
Apr-24-24 12:00PM	The Cooper Companies (COO) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Apr-12-24 09:22AM	Reasons to Hold The Cooper Companies (COO) in Your Portfolio Now (Zacks)
Mar-25-24 02:16PM	20 Best Countries for Migration by Investment (Insider Monkey)
Mar-11-24 08:27AM	Reasons to Add The Cooper Companies (COO) to Your Portfolio Now (Zacks)
Mar-08-24 02:37PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
Mar-01-24 10:41AM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research) +9.18%
07:07AM	Cooper Companies (COO) Q1 Earnings Top, '24 Outlook Raised (Zacks)
Feb-29-24 04:15PM	CooperCompanies Announces First Quarter 2024 Results (GlobeNewswire)
Feb-26-24 09:16AM	Unveiling The Cooper Companies (COO) Q1 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Feb-22-24 10:00AM	The Cooper Companies (COO) Earnings Expected to Grow: Should You Buy? (Zacks)
Feb-21-24 08:01PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
Feb-20-24 11:35AM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
Feb-18-24 01:26PM	25 Most Valuable Medical Device Companies in the US (Insider Monkey)
Feb-15-24 04:15PM	CooperCompanies 4-for-1 Stock Split Effective Friday (2/16) (GlobeNewswire)
Feb-13-24 09:43AM	11 Stocks That May Be Splitting Soon (Insider Monkey)
Feb-12-24 10:31AM	Cooper Companies (COO), Fulgent Unite to Boost Genetic Testing (Zacks)
08:02AM	Reasons to Retain The Cooper Companies (COO) in Your Portfolio Now (Zacks)
Feb-09-24 08:31AM	Cord Blood Registry (CBR) by CooperSurgical and Fulgent Genetics Launch Innovative Genetic Testing (PR Newswire)
Jan-25-24 04:15PM	CooperCompanies Announces Release Date for First Quarter 2024 (GlobeNewswire)
Jan-22-24 04:53AM	Should You Be Positive on The Cooper Companies (COO)'s Outlook? (Insider Monkey)
Jan-05-24 07:48AM	Reasons to Retain The Cooper Companies (COO) in Your Portfolio Now (Zacks)
Dec-21-23 04:15PM	CooperCompanies to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-19-23 04:15PM	CooperCompanies Sets Annual Meeting And Stockholder Record Dates (GlobeNewswire)
Dec-09-23 01:05AM	Decoding The Cooper Companies Inc (COO): A Strategic SWOT Insight (GuruFocus.com)
Dec-08-23 02:11PM	Cooper Companies (COO) Q4 Earnings In Line, '23 Outlook Raised (Zacks)
12:57PM	Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023 (Associated Press Finance)
09:17AM	The Cooper Companies, Inc. (NYSE:COO) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:14AM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
07:15AM	Q4 2023 Cooper Companies Inc Earnings Call (Thomson Reuters StreetEvents)
Dec-07-23 06:00PM	Compared to Estimates, The Cooper Companies (COO) Q4 Earnings: A Look at Key Metrics (Zacks)
05:10PM	The Cooper Companies Inc (COO) Reports Organic Revenue Growth and EPS Increase in Q4 (GuruFocus.com)
04:58PM	Cooper Cos beats revenue estimates on strong demand for contact lens (Reuters)
04:36PM	The Cooper Companies: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:15PM	CooperCompanies Announces Fourth Quarter and Full Year 2023 Results (GlobeNewswire)
Dec-05-23 02:20PM	What's in Store for Cooper Companies (COO) in Q4 Earnings? (Zacks)
Dec-04-23 12:44PM	The Cooper Companies (COO) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
Nov-30-23 04:15PM	CooperCompanies Appoints Lawrence E. Kurzius to Board of Directors (GlobeNewswire)
10:00AM	The Cooper Companies (COO) Earnings Expected to Grow: Should You Buy? (Zacks)
Nov-28-23 09:31AM	Reasons to Retain The Cooper Companies (COO) in Your Portfolio (Zacks)
Nov-24-23 01:25AM	CooperVision to host 3rd APAC Myopia Management Symposium in Taiwan Region (PR Newswire)
Nov-02-23 04:15PM	CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2023 (GlobeNewswire)
Nov-01-23 04:15PM	CooperCompanies Expands CooperSurgical's Medical Device Portfolio with Acquisition of Select Cook Medical Assets (GlobeNewswire)
Oct-30-23 09:43AM	AbbVie upgraded, Cisco downgraded: Wall Street's top analyst calls (The Fly)
Oct-19-23 11:40AM	XRAY or COO: Which Is the Better Value Stock Right Now? (Zacks)

The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
White Albert G III	President & CEO	Jan 08 '25	Option Exercise	0.00	18,340	0	183,613	Jan 10 04:12 PM
Warner Gerard H III	President, CooperVision, Inc.	Jan 08 '25	Option Exercise	0.00	13,328	0	23,763	Jan 10 04:12 PM
Sheffield Holly R	President, CSI	Jan 08 '25	Option Exercise	0.00	4,900	0	30,898	Jan 10 04:11 PM
Ricupati Agostino	SVP & CAO	Jan 08 '25	Option Exercise	0.00	4,472	0	9,328	Jan 10 04:11 PM
McBride Daniel G	EVP & Chief Operating Officer	Jan 08 '25	Option Exercise	0.00	8,728	0	53,424	Jan 10 04:11 PM
Andrews Brian G	EVP, CFO & Treasurer	Jan 08 '25	Option Exercise	0.00	6,420	0	13,034	Jan 10 04:10 PM
Khadder Nicholas	VP, General Counsel & Corp Sec	Jan 08 '25	Option Exercise	0.00	3,492	0	4,369	Jan 10 04:10 PM
White Albert G III	President & CEO	Sep 19 '24	Option Exercise	43.83	114,992	5,040,099	280,265	Sep 20 05:51 PM
White Albert G III	President & CEO	Sep 19 '24	Sale	110.53	114,992	12,710,041	165,273	Sep 20 05:51 PM
Albert G. White III	Officer	Sep 19 '24	Proposed Sale	110.53	114,992	12,709,660		Sep 19 03:53 PM
Ricupati Agostino	SVP & CAO	Apr 01 '24	Option Exercise	0.00	2,076	0	7,472	Sep 11 05:50 PM
Ricupati Agostino	SVP & CAO	Sep 10 '24	Sale	108.03	1,601	172,955	4,818	Sep 11 05:50 PM
Agostino Ricupati	Director	Sep 10 '24	Proposed Sale	108.03	1,601	172,950		Sep 10 01:47 PM
Andrews Brian G	EVP, CFO & Treasurer	Sep 05 '24	Option Exercise	37.91	24,788	939,734	31,402	Sep 06 04:58 PM
Andrews Brian G	EVP, CFO & Treasurer	Sep 05 '24	Sale	105.90	24,788	2,625,072	6,614	Sep 06 04:58 PM
McBride Daniel G	EVP & Chief Operating Officer	Sep 04 '24	Option Exercise	43.83	114,992	5,040,099	159,688	Sep 06 04:56 PM
McBride Daniel G	EVP & Chief Operating Officer	Sep 04 '24	Sale	105.48	114,992	12,129,911	44,696	Sep 06 04:56 PM
Brian G. Andrews	Officer	Sep 05 '24	Proposed Sale	105.90	24,788	2,624,952		Sep 05 01:22 PM
Daniel McBride	Officer	Sep 04 '24	Proposed Sale	105.48	114,992	12,129,545		Sep 04 04:18 PM
WEISS ROBERT S	Director	Apr 01 '24	Option Exercise	0.00	3,180	0	285,952	Apr 03 06:03 PM
Rivas Maria	Director	Apr 01 '24	Option Exercise	0.00	2,892	0	2,892	Apr 03 06:03 PM
MADDEN TERESA S	Director	Apr 01 '24	Option Exercise	0.00	2,892	0	9,636	Apr 03 05:53 PM
Lucchese Cynthia L	Director	Apr 01 '24	Option Exercise	0.00	2,892	0	4,940	Apr 03 05:53 PM
Jay Colleen	Director	Apr 01 '24	Option Exercise	0.00	2,892	0	26,800	Apr 03 05:53 PM
Kurzius Lawrence Erik	Director	Apr 01 '24	Option Exercise	0.00	1,056	0	1,056	Apr 03 05:52 PM
KOZY WILLIAM A	Director	Apr 01 '24	Option Exercise	0.00	3,036	0	28,292	Apr 03 05:52 PM
Ricupati Agostino	SVP & CAO	Mar 18 '24	Option Exercise	69.74	54,724	3,816,317	34,609	Mar 20 06:58 PM
Ricupati Agostino	SVP & CAO	Mar 18 '24	Sale	100.89	54,724	5,521,230	5,081	Mar 20 06:58 PM
WEISS ROBERT S	Director	Mar 07 '24	Option Exercise	57.41	153,213	8,796,724	435,985	Mar 11 05:00 PM
WEISS ROBERT S	Director	Mar 08 '24	Option Exercise	57.41	88,075	5,056,826	370,847	Mar 11 05:00 PM
WEISS ROBERT S	Director	Mar 07 '24	Sale	102.21	153,213	15,659,610	282,772	Mar 11 05:00 PM
WEISS ROBERT S	Director	Mar 08 '24	Sale	102.18	88,075	8,999,732	282,772	Mar 11 05:00 PM
PETERSMEYER GARY S	Director	Mar 05 '24	Sale	103.51	1,000	103,506	5,668	Mar 07 06:05 PM

EYE National Vision Holdings Inc daily Stock Chart

Peers: AMZN WMT COST TGT CVS DG WBA DLTR VSTO FLWS

| Held by: IJR VTI IWM VB VBR VXF IJS FNDA SPSM IWN

Index	RUT	P/E	-	EPS (ttm)	-0.20	Insider Own	2.25%	Shs Outstand	78.69M	Perf Week	2.66%
Market Cap	850.50M	Forward P/E	20.34	EPS next Y	0.53	Insider Trans	0.47%	Shs Float	76.98M	Perf Month	-6.74%
Income	-15.89M	PEG	-	EPS next Q	-0.06	Inst Own	100.04%	Short Float	4.83%	Perf Quarter	6.19%
Sales	1.95B	P/S	0.44	EPS this Y	-19.90%	Inst Trans	-12.12%	Short Ratio	2.65	Perf Half Y	-20.88%
Book/sh	10.67	P/B	1.01	EPS next Y	3.56%	ROA	-0.62%	Short Interest	3.72M	Perf Year	-44.87%
Cash/sh	1.03	P/C	10.48	EPS next 5Y	13.10%	ROE	-1.57%	52W Range	9.56 - 24.11	Perf YTD	3.65%
Dividend Est.	-	P/FCF	32.23	EPS past 5Y	-	ROI	-1.07%	52W High	-55.21%	Beta	1.43
Dividend TTM	-	Quick Ratio	0.37	Sales past 5Y	5.81%	Gross Margin	50.19%	52W Low	12.97%	ATR (14)	0.47
Dividend Ex-Date	-	Current Ratio	0.57	EPS Y/Y TTM	73.25%	Oper. Margin	1.04%	RSI (14)	47.88	Volatility	3.66% 4.21%
Employees	13998	Debt/Eq	0.99	Sales Y/Y TTM	-6.55%	Profit Margin	-0.81%	Recom	2.36	Target Price	13.60
Option/Short	Yes / Yes	LT Debt/Eq	0.76	EPS Q/Q	88.59%	Payout	-	Rel Volume	1.53	Prev Close	10.75
Sales Surprise	0.09%	EPS Surprise	85.76%	Sales Q/Q	-15.19%	Earnings	Nov 06 BMO	Avg Volume	1.40M	Price	10.80
SMA20	0.12%	SMA50	-4.17%	SMA200	-15.42%	Trades		Volume	2,139,945	Change	0.47%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-17-23	Downgrade	Goldman	Buy → Neutral	$25 → $16
Jul-27-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$30 → $21
Jul-27-23	Downgrade	Citigroup	Buy → Neutral	$28 → $22
May-02-23	Downgrade	Barclays	Overweight → Equal Weight
Mar-31-23	Upgrade	Loop Capital	Hold → Buy	$23
Jan-17-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-07-22	Resumed	Jefferies	Buy	$40 → $45
Jun-27-22	Upgrade	Goldman	Neutral → Buy	$31 → $32
Nov-15-21	Downgrade	Goldman	Buy → Neutral	$59 → $57
Nov-12-21	Downgrade	BofA Securities	Buy → Underperform	$63 → $50
Oct-14-21	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$70
Aug-27-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$58 → $57
Jan-11-21	Downgrade	Loop Capital	Buy → Hold
Nov-18-20	Downgrade	Berenberg	Buy → Hold	$42
Feb-04-20	Initiated	BMO Capital Markets	Market Perform
Feb-03-20	Initiated	BMO Capital Markets	Market Perform
Nov-13-19	Initiated	Barclays	Overweight	$34
Oct-01-19	Upgrade	BofA/Merrill	Neutral → Buy
Aug-07-19	Upgrade	Loop Capital	Hold → Buy	$30 → $37
Jul-11-19	Initiated	Goldman	Buy	$33

Show Previous Ratings

Jan-17-25 03:12PM	National Vision on hunt for new CFO; announces leadership changes (Chain Store Age)
12:31PM	National Vision announces promotions as CFO departs (Chain Store Age)
Jan-16-25 04:09PM	Mueller Water Products Appoints Melissa Rasmussen as Chief Financial Officer (GlobeNewswire)
04:05PM	National Vision Announces Leadership Changes (Business Wire)
Jan-14-25 04:03AM	3 Reasons to Sell EYE and 1 Stock to Buy Instead (StockStory)
04:05AM	Loading…
Jan-13-25 04:05AM	Specialty Retail Stocks Q3 Results: Benchmarking Petco (NASDAQ:WOOF) (StockStory)
Jan-06-25 04:07AM	Q3 Earnings Recap: National Vision (NASDAQ:EYE) Tops Specialty Retail Stocks (StockStory)
Dec-26-24 04:04AM	Q3 Earnings Highlights: Leslie's (NASDAQ:LESL) Vs The Rest Of The Specialty Retail Stocks (StockStory)
Dec-16-24 03:32AM	Unpacking Q3 Earnings: Tractor Supply (NASDAQ:TSCO) In The Context Of Other Specialty Retail Stocks (StockStory)
Dec-06-24 11:31AM	National Vision (EYE) Down 4.6% Since Last Earnings Report: Can It Rebound? (Zacks)
Nov-07-24 06:34AM	National Vision Holdings Reports Revenue Growth Amid Challenges (TipRanks)
Nov-06-24 06:23AM	National Vision Reaffirms FY23 Outlook - Update (RTT News)
06:21AM	National Vision: Q3 Earnings Snapshot (Associated Press Finance)
06:07AM	National Vision (NASDAQ:EYE) Posts Q3 Sales In Line With Estimates (StockStory)
06:00AM	National Vision Holdings, Inc. Reports Third Quarter 2024 Financial Results (Business Wire)
05:59AM	Loading…
05:59AM	National Vision Completes Comprehensive Review of Store Fleet (Business Wire)
Nov-05-24 07:53AM	National Vision Holdings Inc (EYE) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-23-24 08:00AM	National Vision Holdings, Inc. Announces Third Quarter 2024 Earnings Release and Conference Call (Business Wire)
Oct-16-24 04:53AM	Specialty Retail Stocks Q2 In Review: Petco (NASDAQ:WOOF) Vs Peers (StockStory)
04:53AM	Specialty Retail Stocks Q2 Recap: Benchmarking Tractor Supply (NASDAQ:TSCO) (StockStory)
Oct-09-24 08:03AM	National Vision Opens 2024-2025 Scholarship Program, Highlighting AIs Role in the Future of Eye Care (Business Wire)
Sep-27-24 04:52AM	Spotting Winners: National Vision (NASDAQ:EYE) And Specialty Retail Stocks In Q2 (StockStory)
Sep-24-24 08:37AM	America's Best Becomes Exclusive Retail Partner of Pair Eyewear, Bringing Swappable Frames to 1,000+ Stores (PR Newswire)
Sep-12-24 06:33AM	Meridian Contrarian Fund Trimmed National Vision Holdings (EYE) in Q2. Heres Why (Insider Monkey)
01:12AM	William Blair Investment Management, LLC Reduces Stake in National Vision Holdings Inc (GuruFocus.com)
Sep-06-24 09:48AM	Implied Volatility Surging for National Vision (EYE) Stock Options (Zacks) -5.00%
Aug-28-24 08:00AM	National Vision Holdings, Inc. Announces Participation in the Goldman Sachs 31st Annual Global Retailing Conference (Business Wire)
Aug-27-24 08:00AM	National Vision Releases 2023 Sustainability Report (Business Wire)
Aug-20-24 01:22PM	Florence by Mills Launches New Fashion-Forward Eyewear Collection Exclusively in America's Best Stores (PR Newswire)
Aug-08-24 08:25AM	National Vision (EYE) Tops Q2 Earnings, Lowers '24 Outlook (Zacks)
06:00AM	Loading…
06:00AM	National Vision Holdings, Inc. Announces Repurchase of $218 Million of Convertible Notes and Borrowing of $115 Million in Incremental Term Loans (Business Wire)
Aug-07-24 06:17AM	National Vision (NASDAQ:EYE) Reports Q2 In Line But Stock Drops on Guide 24.8% (StockStory) -21.70%
06:15AM	National Vision: Q2 Earnings Snapshot (Associated Press Finance)
06:01AM	National Vision Holdings, Inc. Reports Second Quarter 2024 Financial Results (Business Wire)
06:00AM	National Vision Announces the Appointment of Alex Wilkes as President (Business Wire)
Aug-01-24 04:30PM	National Vision Appoints Caitlin Zulla to Board of Directors (Business Wire) -6.09%
Jul-24-24 08:00AM	National Vision Holdings, Inc. Announces Second Quarter 2024 Earnings Release and Conference Call (Business Wire)
08:00AM	National Vision Announces Optometry Students Selected to Win $7,000 in Scholarships (Business Wire)
Jul-22-24 03:19AM	Q1 Earnings Outperformers: National Vision (NASDAQ:EYE) And The Rest Of The Specialty Retail Stocks (StockStory)
Jul-15-24 09:40AM	Are Investors Undervaluing National Vision (EYE) Right Now? (Zacks)
Jul-12-24 11:11AM	Strength Seen in National Vision (EYE): Can Its 7.2% Jump Turn into More Strength? (Zacks)
Jul-05-24 11:50AM	Optical retailer taps Sleep Number leader for C-suite role (Chain Store Age)
Jul-01-24 04:15PM	National Vision Welcomes Mark Banner as New Chief Stores Officer (Business Wire)
08:55AM	National Vision (EYE) Gains Market Share Despite Macro Woes (Zacks)
Jun-25-24 08:30AM	National Vision Gathers More Than 1,000 Optometrists at Annual Continuing Education Symposium (Business Wire)
Jun-07-24 11:30AM	National Vision (EYE) Down 4% Since Last Earnings Report: Can It Rebound? (Zacks)
Jun-04-24 08:30AM	National Vision Expands Access to Affordable Eye Care and Eyewear with Opening of 1,000th Americas Best Store (Business Wire)
May-29-24 08:00AM	National Vision Holdings, Inc. to Participate in Upcoming Investor Conferences (Business Wire)
May-16-24 08:41AM	3 Retail Stocks That Could Collapse in the E-Commerce Shakeout (InvestorPlace)
May-09-24 12:59PM	National Vision Holdings, Inc. (NASDAQ:EYE) Q1 2024 Earnings Call Transcript (Insider Monkey)
10:01AM	National Vision (EYE) Q1 Earnings Beat Estimates, Margins Down (Zacks)
May-08-24 07:34AM	National Vision Holdings Inc (EYE) Q1 2024 Earnings: Mixed Results Amidst Strategic Shifts (GuruFocus.com) -16.62%
07:15AM	National Vision (EYE) Q1 Earnings Top Estimates (Zacks)
06:30AM	National Vision Q1 Income From Cont. Ops. Declines (RTT News)
06:18AM	National Vision: Q1 Earnings Snapshot (Associated Press Finance)
06:11AM	National Vision (NASDAQ:EYE) Reports Sales Below Analyst Estimates In Q1 Earnings (StockStory)
06:00AM	National Vision Holdings, Inc. Reports First Quarter 2024 Financial Results (Business Wire)
May-02-24 06:16AM	Stock Market Crash Warning: Don't Get Caught Holding These 3 Russell 2000 Stocks (InvestorPlace)
May-01-24 10:01AM	Earnings Preview: National Vision (EYE) Q1 Earnings Expected to Decline (Zacks)
Apr-28-24 07:00AM	3 Brick-and-Mortar Retail Stocks to Sell as In-Store Sales Struggle (InvestorPlace)
Apr-24-24 08:00AM	National Vision Holdings, Inc. Announces First Quarter 2024 Earnings Release and Conference Call (Business Wire) -5.89%
Apr-19-24 04:44AM	Q4 Rundown: Petco (NASDAQ:WOOF) Vs Other Specialty Retail Stocks (StockStory)
Apr-17-24 03:41AM	Specialty Retail Stocks Q4 Earnings Review: National Vision (NASDAQ:EYE) Shines (StockStory)
Apr-08-24 06:56AM	Q4 Earnings Outperformers: Tractor Supply (NASDAQ:TSCO) And The Rest Of The Specialty Retail Stocks (StockStory)
05:12AM	Specialty Retail Stocks Q4 In Review: Leslie's (NASDAQ:LESL) Vs Peers (StockStory)
Mar-28-24 11:30AM	National Vision (EYE) Down 4.1% Since Last Earnings Report: Can It Rebound? (Zacks)
Mar-21-24 08:10AM	Here's Why You Should Retain National Vision (EYE) Stock Now (Zacks)
Mar-12-24 08:30AM	National Vision Awards Trio of Optometry Students $12,500 in Ninth Annual Scholarship Program (Business Wire)
Mar-06-24 07:30AM	National Vision Holdings, Inc. Announces Participation in the UBS Global Consumer and Retail Conference (Business Wire)
Feb-29-24 08:01AM	National Vision (EYE) Q4 Earnings Top Estimates, Margins Fall (Zacks)
Feb-28-24 09:04AM	National Vision Holdings, Inc. (NASDAQ:EYE) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 11:19PM	Q4 2023 National Vision Holdings Inc Earnings Call (Thomson Reuters StreetEvents) +15.78%
06:23AM	National Vision: Q4 Earnings Snapshot (Associated Press Finance)
06:15AM	National Vision Guides FY24 In Line With Estimates - Update (RTT News)
06:12AM	National Vision's (NASDAQ:EYE) Q4: Beats On Revenue (StockStory)
06:10AM	National Vision Holdings Inc (EYE) Reports Mixed Fiscal 2023 Results Amidst Walmart Partnership ... (GuruFocus.com)
06:00AM	National Vision Holdings, Inc. Reports Fourth Quarter and Fiscal 2023 Financial Results (Business Wire)
Feb-13-24 08:00AM	National Vision Holdings, Inc. Announces Fourth Quarter and Fiscal 2023 Earnings Release and Conference Call (Business Wire) -6.54%
Feb-08-24 08:00AM	National Vision Appoints Susan OFarrell to Board of Directors (Business Wire)
Jan-30-24 09:00AM	Vontlle Brings Diverse Eyewear to National Shelves with Official Frame Collection at America's Best (PR Newswire)
Jan-26-24 08:00AM	NACD Atlanta Appoints New Board Chair, Cindy Baerman, and Board Director, Jared Brandman (PR Newswire)
Jan-22-24 03:04AM	Specialty Retail Q3 Earnings: National Vision (NASDAQ:EYE) is the Best in the Biz (StockStory)
Jan-19-24 12:14AM	Specialty Retail Stocks Q3 Recap: Benchmarking Tractor Supply (NASDAQ:TSCO) (StockStory)
Jan-17-24 08:00AM	Pair Eyewear Launches Collaboration with Leading Optical Retailer National Vision (Business Wire)
Jan-15-24 01:26AM	A Look Back at Specialty Retail Stocks' Q3 Earnings: Petco (NASDAQ:WOOF) Vs The Rest Of The Pack (StockStory)
Jan-12-24 07:19AM	National Vision Holdings (EYE) Fell on Multiple Challenges (Insider Monkey)
Jan-09-24 08:35AM	Here's Why You Should Retain National Vision (EYE) Stock Now (Zacks)
Dec-07-23 06:59AM	Here's Why You Should Retain National Vision (EYE) Stock Now (Zacks)
Nov-10-23 02:10PM	National Vision Holdings, Inc. (NASDAQ:EYE) Q3 2023 Earnings Call Transcript (Insider Monkey) +6.29%
08:08AM	National Vision (EYE) Q3 Earnings Top Estimates, Margins Fall (Zacks)
07:34AM	National Vision Holdings, Inc. Announces Repurchase of $100 Million of Convertible Notes (Business Wire)
Nov-09-23 07:04AM	National Vision Holdings Inc (EYE) Faces Net Loss in Q3 2023 Amid Walmart Partnership ... (GuruFocus.com)
06:39AM	National Vision Boosts FY23 Outlook As Q3 Results Top Estimates (RTT News)
06:37AM	National Vision: Q3 Earnings Snapshot (Associated Press Finance)
06:28AM	National Vision (NASDAQ:EYE) Q3: Beats On Revenue (StockStory)
06:00AM	National Vision Holdings, Inc. Reports Third Quarter 2023 Financial Results (Business Wire)
Oct-31-23 08:00AM	National Vision Holdings, Inc. Announces Participation in the Jefferies London Healthcare Conference (Business Wire)
Oct-26-23 08:00AM	National Vision Holdings, Inc. Announces Third Quarter 2023 Earnings Release and Conference Call (Business Wire)
Oct-19-23 08:30AM	National Vision Puts Pediatric Eye Care in Focus for 2023-2024 Scholarship Program (Business Wire)
Oct-05-23 04:31PM	National Vision Releases 2022 Sustainability Report (Business Wire)

National Vision Holdings, Inc. engages in the retail of optical products. It operates through the following segments: Owned and Host, Legacy, and Corporate and Other. The Owned and Host segment offers America's Best and Eyeglass World brands. The Legacy segment includes inventory and lab processing services. The Corporate and Other segment relates to the results of operations of the other operating segments and corporate overhead support. The company was founded in 1990 and is headquartered in Duluth, GA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Moore Patrick R.	Special Advisor	Aug 23 '24	Option Exercise	7.25	21,360	154,860	84,542	Aug 27 04:16 PM
Moore Patrick R.	Special Advisor	Aug 23 '24	Sale	10.52	17,661	185,794	66,881	Aug 27 04:16 PM
Moore Patrick R.	Officer	Aug 23 '24	Proposed Sale	10.52	17,661	185,798		Aug 23 12:31 PM
PEELER D RANDOLPH	Director	Aug 13 '24	Buy	10.57	25,000	264,200	207,880	Aug 14 04:27 PM
Hepner Virginia A	Director	Aug 12 '24	Buy	10.37	1,000	10,365	36,635	Aug 14 04:26 PM
FAHS L READE	Chief Executive Officer	May 13 '24	Buy	14.96	20,000	299,200	633,097	May 14 08:01 AM
PEELER D RANDOLPH	Director	May 10 '24	Buy	14.45	34,000	491,198	182,880	May 14 08:00 AM
Acharya Ravi	SVP, Chief Technology Officer	Mar 05 '24	Option Exercise	0.00	2,556	0	16,563	Mar 07 04:19 PM
Clark Bill	SVP, Chief People Officer	Mar 05 '24	Option Exercise	0.00	2,556	0	32,925	Mar 07 04:17 PM
Rasmussen Melissa	Chief Financial Officer	Mar 05 '24	Option Exercise	0.00	1,279	0	21,689	Mar 07 04:16 PM
Brandman Jared	SVP, GC and Secretary	Mar 05 '24	Option Exercise	0.00	2,556	0	36,030	Mar 07 04:15 PM
Moore Patrick R.	Chief Operating Officer	Mar 05 '24	Option Exercise	0.00	5,111	0	64,708	Mar 07 04:13 PM
FAHS L READE	Chief Executive Officer	Mar 05 '24	Option Exercise	0.00	20,078	0	619,089	Mar 07 04:11 PM

BLCO Bausch + Lomb Corp daily Stock Chart

Peers: JNJ ALGN NVO TEVA PFE MRK CRL DHR ABT EXAS

| Held by: MGMT IPO DFIC DFAX DFSI QRFT EVNT

Index	-	P/E	-	EPS (ttm)	-1.05	Insider Own	90.08%	Shs Outstand	352.08M	Perf Week	-2.25%
Market Cap	6.11B	Forward P/E	21.28	EPS next Y	0.82	Insider Trans	0.01%	Shs Float	34.93M	Perf Month	-6.42%
Income	-368.00M	PEG	-	EPS next Q	0.24	Inst Own	9.51%	Short Float	3.48%	Perf Quarter	-16.42%
Sales	4.68B	P/S	1.31	EPS this Y	-19.13%	Inst Trans	-8.99%	Short Ratio	2.48	Perf Half Y	2.54%
Book/sh	18.71	P/B	0.93	EPS next Y	38.16%	ROA	-2.77%	Short Interest	1.22M	Perf Year	17.85%
Cash/sh	0.99	P/C	17.47	EPS next 5Y	13.00%	ROE	-5.49%	52W Range	13.16 - 21.69	Perf YTD	-3.88%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-3.29%	52W High	-19.96%	Beta	0.47
Dividend TTM	-	Quick Ratio	0.95	Sales past 5Y	2.69%	Gross Margin	54.48%	52W Low	31.91%	ATR (14)	0.49
Dividend Ex-Date	-	Current Ratio	1.57	EPS Y/Y TTM	-77.31%	Oper. Margin	4.04%	RSI (14)	37.48	Volatility	2.74% 2.57%
Employees	13300	Debt/Eq	0.70	Sales Y/Y TTM	18.01%	Profit Margin	-7.86%	Recom	2.38	Target Price	20.92
Option/Short	Yes / Yes	LT Debt/Eq	0.70	EPS Q/Q	104.72%	Payout	-	Rel Volume	1.45	Prev Close	17.44
Sales Surprise	1.96%	EPS Surprise	8.07%	Sales Q/Q	18.77%	Earnings	Oct 30 BMO	Avg Volume	489.87K	Price	17.36
SMA20	-2.38%	SMA50	-8.07%	SMA200	1.72%	Trades		Volume	711,200	Change	-0.46%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-11-24	Downgrade	Citigroup	Buy → Neutral	$24 → $22
Dec-02-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$19
Oct-15-24	Upgrade	Evercore ISI	In-line → Outperform	$19 → $25
Jul-10-24	Initiated	Raymond James	Outperform	$19
May-06-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$16 → $18
Jan-04-24	Downgrade	Evercore ISI	Outperform → In-line	$19 → $17
Dec-12-23	Initiated	Stifel	Hold	$16
Oct-03-23	Resumed	Evercore ISI	Outperform	$20
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$20
Mar-09-23	Initiated	Needham	Hold
Dec-21-22	Initiated	Barclays	Equal Weight	$17
Sep-12-22	Initiated	H.C. Wainwright	Buy	$21
Jul-26-22	Initiated	RBC Capital Mkts	Outperform	$22
Jun-24-22	Initiated	Evercore ISI	Outperform	$21
Jun-06-22	Initiated	Citigroup	Buy
May-31-22	Initiated	Wells Fargo	Overweight	$23
May-31-22	Initiated	Morgan Stanley	Equal-Weight	$22
May-31-22	Initiated	JP Morgan	Neutral	$20
May-31-22	Initiated	Jefferies	Buy	$25
May-31-22	Initiated	Guggenheim	Buy	$24

Show Previous Ratings

Jan-13-25 07:00AM	Bausch + Lomb Bolsters Pipeline with Acquisition of Whitecap Biosciences (Business Wire)
06:00AM	Bausch + Lomb Launches enVista Aspire Intermediate Optimized Monofocal and Toric Intraocular Lenses in the European Union (Business Wire)
Jan-12-25 09:30AM	Is Bausch + Lomb (BLCO) the Best Medical Stock to Buy Under $20? (Insider Monkey)
Jan-07-25 07:00AM	Bausch + Lomb and Glaucoma Research Foundation Launch Second Annual Faces of Glaucoma Campaign and Fundraising Challenge (Business Wire)
Jan-03-25 06:46AM	Bausch + Lomb price target lowered to $22 from $25 at Evercore ISI (TipRanks)
07:00AM	Loading…
Jan-02-25 07:00AM	Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-13-24 10:45AM	BofA rates Bausch & Lomb underperform with lower buyout chances (Investing.com)
Dec-12-24 07:00AM	Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb (ACCESSWIRE)
07:00AM	Bausch + Lomb Responds to Rumors of a Potential Sale (Business Wire)
Dec-11-24 02:14PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research) -12.06%
06:59AM	Bausch + Lomb Acquires Elios Vision, Significantly Enhances Glaucoma Treatment Capabilities (Business Wire)
Nov-22-24 02:31PM	Bausch & Lomb Corporation (BLCO)-A Bull Case Theory (Insider Monkey)
02:31PM	Bausch and#038; Lomb Corporation (BLCO)-A Bull Case Theory (Insider Monkey)
Nov-14-24 07:00AM	Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue Eye Care Recycling Programs (Business Wire)
Oct-31-24 03:06AM	Bausch & Lomb Corp (BLCO) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
05:52PM	Loading…
Oct-30-24 05:52PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
07:00AM	Bausch + Lomb Announces Third-Quarter 2024 Results (Business Wire)
Oct-29-24 09:05AM	Bausch & Lomb Corp (TSX:BLCO) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-23-24 09:45AM	Bausch + Lomb price target raised to $23 from $20 at RBC Capital (TipRanks)
Oct-14-24 11:38AM	Bausch + Lomb Stock Pops as TPG, Blackstone Consider Joint Bid (Investopedia) +7.19%
10:57AM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
07:00AM	Bausch + Lomb Receives FDA Approval for enVista Envy Full Range of Vision Intraocular Lens (Business Wire)
Oct-09-24 08:00AM	Bausch + Lomb Will Release Third-Quarter 2024 Financial Results on October 30 (Business Wire)
Oct-02-24 08:40AM	Bausch + Lomb price target raised to $19 from $17 at Evercore ISI (TipRanks)
Oct-01-24 07:00AM	Bausch + Lomb Launches Opal Digital Marketplace in the United States (Business Wire)
Sep-18-24 11:01AM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research) +7.76%
Sep-16-24 06:35PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research) +14.47%
12:26PM	Bausch + Lomb Stock Jumps Amid Reports Of A Sale (Investopedia)
09:52AM	Stocks to Watch Monday: DJT, Apple, Pfizer, Intel (The Wall Street Journal)
07:22AM	Bausch + Lomb explores sale amid parent company's debt woes - report (Investing.com)
11:37PM	Loading…
Aug-07-24 11:37PM	Insider Buying: CEO Brent Saunders Acquires Shares of Bausch & Lomb Corp (GuruFocus.com)
Aug-05-24 06:45PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research) -5.70%
Aug-01-24 10:41AM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
Jul-31-24 03:55PM	Bausch + Lomb CEO Brent Saunders on growth opportunities (CNBC TV)
12:08PM	Bausch + Lomb CEO on strength in eye care, competitive positioning (CNBC TV)
07:00AM	Bausch + Lomb Announces Second-Quarter 2024 Results (Business Wire)
Jul-30-24 06:33PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
Jul-25-24 06:33PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
Jul-24-24 06:24PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research) -5.05%
Jul-17-24 06:53PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
Jul-11-24 12:05PM	Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31 (Business Wire)
Jul-08-24 07:00AM	Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief (Business Wire)
Jun-17-24 07:00AM	Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress (Business Wire)
Jun-10-24 07:00AM	Bausch + Lomb INFUSE for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States (Business Wire)
Jun-03-24 07:00AM	Bausch + Lomb Launches Blink NutriTears Clinically Proven Nutritional Supplement for Dry Eyes in the United States (Business Wire)
May-29-24 04:30PM	Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results (Business Wire)
May-28-24 09:00AM	Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometrys Meeting (Business Wire)
06:59AM	Bausch + Lomb Receives Health Canada Approval for enVista Envy* Full Visual Range Intraocular Lens (Business Wire)
May-03-24 04:06PM	Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Call Transcript (Insider Monkey) +6.18%
03:35PM	Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-02-24 03:03PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
May-01-24 11:54AM	BLCO Stock Earnings: Bausch & Lomb Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace) -5.50%
08:33AM	Bausch & Lomb Corp (BLCO) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Net Loss Widening (GuruFocus.com)
06:58AM	Bausch + Lomb Announces First-Quarter 2024 Results (Business Wire)
Apr-29-24 07:00AM	Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting (Business Wire)
Apr-25-24 08:30AM	Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes (Business Wire)
Apr-24-24 10:01AM	Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-18-24 07:00AM	Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs (Business Wire)
Apr-15-24 12:00PM	Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1 (Business Wire)
Mar-27-24 07:00AM	Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting (Business Wire)
Mar-25-24 12:00PM	All You Need to Know About Bausch + Lomb (BLCO) Rating Upgrade to Buy (Zacks)
Mar-20-24 12:20PM	Surging Earnings Estimates Signal Upside for Bausch + Lomb (BLCO) Stock (Zacks)
Mar-19-24 08:50AM	Eyenovia, Inc. (NASDAQ:EYEN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-08-24 10:10AM	Issuer Direct Corporation (AMEX:ISDR) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 08:00AM	Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors (Business Wire)
Feb-23-24 03:05PM	Bausch + Lomb CEO Brent Saunders goes one-on-one with Jim Cramer (CNBC TV)
Feb-22-24 11:30AM	Bausch + Lomb Corporation (NYSE:BLCO) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-21-24 10:35PM	Q4 2023 Bausch + Lomb Corp Earnings Call (Thomson Reuters StreetEvents) +13.78%
07:04PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
09:30AM	Compared to Estimates, Bausch + Lomb (BLCO) Q4 Earnings: A Look at Key Metrics (Zacks)
07:36AM	Bausch + Lomb Q4 Adj. Net Income Rises (RTT News)
07:31AM	Bausch & Lomb Corp (BLCO) Reports Robust Revenue Growth Amidst Net Loss in Q4 and Full-Year 2023 (GuruFocus.com)
07:00AM	Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO (GlobeNewswire)
06:58AM	Bausch + Lomb Announces Fourth-Quarter and Full-Year 2023 Results and Provides 2024 Guidance (Business Wire)
Feb-15-24 09:15AM	Seeking Clues to Bausch + Lomb (BLCO) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
Feb-14-24 12:10PM	Will Bausch + Lomb (BLCO) Beat Estimates Again in Its Next Earnings Report? (Zacks)
10:00AM	Bausch + Lomb (BLCO) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Feb-05-24 12:00PM	Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2023 Financial Results on February 21 (Business Wire)
Jan-17-24 06:54PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
Jan-09-24 12:41PM	Bausch + Lomb CEO: 2024 is the biggest year of new product launches the company has ever seen (CNBC TV)
Jan-08-24 06:59AM	Bausch + Lomb Receives FDA Approval for TENEO Excimer Laser Platform for Myopia and Myopic Astigmatism LASIK Vision Correction Surgery (Business Wire)
Jan-03-24 09:00AM	Bausch + Lomb to Participate in the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Nov-28-23 01:25PM	Bausch + Lomb CEO Brent Saunders Pays $35.35 Million for Chers Former Miami Beach Home (The Wall Street Journal)
Nov-15-23 06:59AM	Bausch + Lomb Reports More Than 76 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue Eye Care Recycling Programs (Business Wire)
Nov-03-23 11:01AM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
Nov-01-23 03:19PM	Analyst Report: Bausch + Lomb Corporation (Morningstar Research)
09:21AM	Bausch & Lomb Corp (BLCO) Reports Q3 2023 Earnings and Raises Full-Year Guidance (GuruFocus.com)
06:58AM	Bausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance (Business Wire)
Oct-26-23 06:59AM	Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Ophthalmology Annual Meeting (Business Wire)
Oct-16-23 12:00PM	Bausch + Lomb Will Release Third-Quarter 2023 Financial Results on November 1 (Business Wire)
Oct-04-23 06:59AM	Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Optometry Annual Meeting (Business Wire)
Sep-29-23 10:15AM	Bausch Health's Bausch + Lomb Announces Completion of the Acquisition of XIIDRA(R) (ACCESSWIRE)
10:00AM	Bausch + Lomb Completes Acquisition of XIIDRA (Business Wire)
Sep-26-23 06:59AM	Bausch + Lomb Launches LUMIFY EYE ILLUMINATIONS in the United States (Business Wire)
Sep-20-23 06:59AM	Bausch + Lombs ONE by ONE and Biotrue® Eye Care Recycling Programs Recognized As Sustainability Service of the Year Award Winners (Business Wire)
Sep-19-23 08:32AM	Is the Options Market Predicting a Spike in Bausch + Lomb (BLCO) Stock? (Zacks)
Sep-18-23 11:56AM	Novartis' (NVS) Shareholders Approve Sandoz Separation (Zacks)
Sep-14-23 05:25PM	Bausch + Lomb Announces Pricing of Senior Secured Notes Offering (Business Wire)
Sep-12-23 06:59AM	Bausch + Lomb Launches MIEBO (Perfluorohexyloctane Ophthalmic Solution) in the United States (Business Wire)
Sep-11-23 08:00AM	Bausch Health's Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA(R) (ACCESSWIRE)

Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SAUNDERS BRENT L	CEO and Chairman of the Board	Aug 05 '24	Buy	15.66	32,250	505,067	595,169	Aug 07 05:29 PM

RXST

RxSight Inc

STAA

Staar Surgical Co

WRBY

Warby Parker Inc

LUCY

Innovative Eyewear Inc

COO

Cooper Companies, Inc

EYE

National Vision Holdings Inc

BLCO

Bausch + Lomb Corp

Upgrade your FINVIZ experience